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Lower respiratory tract infection associated with bacterial pathogens is a major cause of 
morbidity and mortality globally. As a result of the large volume of inhaled air, inevitably 
the lower respiratory tract is exposed to foreign substances, such as pathogens and 
allergens. Hence, to maintain homeostasis and sterility, the lower respiratory tract is 
equipped with multiple barriers and cells with distinct functions. Tightly connected ciliated 
epithelial cells are the first lining of the conducting airway, covered by a thin layer of mucus. 
Serving as physical barriers, mucus and the epithelium regulate mucociliary clearance 
and separate harmful particles from professional immune cells. On the other hand, the 
chemical barrier consists of secreted products, such as mucin, lytic enzymes, and 
antimicrobial peptides. In addition to epithelial cells, dendritic cells and macrophages are 
found in the lower respiratory tract. When epithelial cells are confronted with invading 
pathogens, bacterial ligands are recognised by receptors such as Toll-like receptors (TLR), 
which leads to sequential events, comprising activation of signalling cascades, expression 
and secretion of pro-inflammatory cytokines and chemokines, and recruitment and 
activation of professional immune cells. To bypass the immune response and facilitate 
successful infection, pathogens have evolved a wide range of virulence factors that 
subvert the host response at multiple steps.  
The aims of this thesis were to investigate the differences in host responses to mono- and 
co-infection by common pulmonary pathogens Staphylococcus aureus and Burkholderia 
cepacia complex, to interpret the host receptor and signalling cascades targeted by S. 
aureus, and to characterise S. aureus immunomodulatory factors. Disruption of the intact 
airway epithelial barrier and cellular internalisation were observed with both species. B. 
cenocepacia J2315 activated TLR-mediated MAPK and NF-κB signalling pathways, 
subsequently eliciting a robust interleukin (IL)-8 production. However, when airway 
epithelial cells were co-treated with B. cenocepacia live bacteria and S. aureus 
supernatants, the pro-inflammatory response was subverted by Staphylococcal effectors. 
This anti-inflammatory effect was widely exhibited in S. aureus isolates tested, and was 
mediated via TLRs but not via the IL-1 receptor or the tumour necrosis factor receptor. 
TLR4 but not TLR5 was partially blocked by S. aureus secreted products, though the 
TLR4 agonist lipopolysaccharide did not affect IL-8 expression at a high concentration. 
The Staphylococcal effectors were preliminarily characterised as small, heat-stable, non-
proteinaceous, and not cell wall-related factors.  
This thesis demonstrates the complex nature of host response in a co-infection model and 
provides insight into a novel S. aureus immune evasion mechanism, as well as a 
therapeutic intervention of abnormal chronic inflammation. 
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 Microbial infections of the lower respiratory tract  
1.1.1 Overview of lower respiratory tract infection  
Lower respiratory tract infection (LRTI) is infection and inflammation caused by bacterial, 
fungal, parasitic or viral microorganisms in the trachea, bronchi and lungs. Depending on 
the rate at which it is spontaneously resolved by antibiotic treatments, it is defined as an 
acute or chronic illness, with cough and other symptoms including sputum production, 
dyspnoea, wheeze or chest discomfort/pain, with no alternative explanation (Woodhead 
et al., 2011). In contrast to relative short recovery period and less residual impact on the 
lower respiratory tract in the case of acute infections, insufficient but unrelenting immune 
responses and inefficient antibiotic therapies cause persistent chronic infections and 
exacerbations of pulmonary dysfunction. Chronic LRTI occurs often in patients with 
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and non-CF 
bronchiectasis (Pragman et al., 2016). Children younger than 5 years and 
immunocompromised people are prone to LRTI and have severe illness. LRTI is the 
leading infectious cause and the fifth-leading cause of morbidity and mortality globally 
(Troeger et al., 2017). In 2015, mortality due to LRTI was 2.74 million in all ages and 0.7 
million deaths in children younger than 5 years. Childhood undernutrition and air pollution 
are the major risk factors. According to the Global Burden of Disease Study, four 
aetiologies associated with LRTI are Haemophilus influenzae type B, Streptococcus 
pneumoniae, influenza and respiratory syncytial virus infection (Troeger et al., 2017). 
Although viral causes are the main causes for mild to moderate LRTI, bacterial pneumonia 
results in higher mortality compared to viral causes. S. pneumoniae leads to 55% of LRTI 
deaths in all ages as the most common cause and Haemophilus influenzae type B is 
mainly attributed to mortality in children younger than 5 years. Fortunately, vaccines 
against Haemophilus influenzae type B and S. pneumoniae are available and thus 
vaccination might reduce the occurrence of bacterial LRTI, in addition to antibiotics. Apart 
from the aetiologies mentioned above, the opportunistic pathogen S. aureus is another 
common causative agent in LRTI, particularly in hospital- and community-acquired 
settings, owing to the emergence of multi-drug resistance (Jones, 2010; Udo, 2013). Other 
common bacterial organisms are Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Escherichia coli, and Burkholderia cepacia complex (Bcc) (Uzoamaka et al., 2017).  
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1.1.2 Dilemmas of antibiotic resistance  
Antibiotics are the most commonly used treatment for LRTI. However, there are many 
limitations and adverse effects, including no effect on viral infections, rapid development 
of resistance, and side effects such as gastrointestinal disturbances. With the emergence 
of multi-antibiotic resistant isolates, effective treatments become more complicated, 
resulting in higher medical cost. The definition of antibiotic resistance is the ability of 
microbes to grow in the presence of antimicrobial agents at a concentration that would 
normally inhibit the growth (Brauner et al., 2016). Resistance is usually determined by 
measuring the minimum inhibitory concentration of planktonic (free floating) 
microorganisms, which acquire resistance either by chromosomal mutations or horizontal 
gene transfer of mobile genetic elements (Foster, 2017). Although antibiotic resistance 
evolves naturally, misuse or overuse of antibiotics accelerates this process. Therefore, it 
is critical to control and prevent infections, coupled with better stewardship of antibiotics.  
S. aureus is a Gram-positive, opportunistic pathogen and readily acquires mobile genetic 
elements to develop antibiotic resistance using a variety of mechanisms (Haaber et al., 
2017). Firstly, S. aureus acquires resistance to broad-spectrum β-lactams such as 
penicillin by acquiring plasmids that expresses β-lactamase. Soon after the clinical use of 
β-lactamase-stable derivatives such as methicillin, S. aureus adopted Staphylococcal 
cassette chromosomal element (SCCmec, encoding penicillin binding protein 2a) which 
confers resistance to β-lactams. These isolates are called methicillin-resistant S. aureus 
(MRSA) (Foster, 2017; Jevons, 1961). Alternative antibiotics choices include vancomycin 
(glycopeptide), tetracycline (tetracycline), fusidic acid (steroid-like antibiotic), and linezolid 
(oxazolidinone). However, resistant phenotypes towards these alternatives have emerged, 
posing significant challenges on S. aureus treatment (Gardete and Tomasz, 2014; Gu et 
al., 2012; McLaws et al., 2011; Schmitz, 2001). 
Another opportunistic pathogen, Bcc is a group of at least 20 closely related Gram-
negative, motile bacteria and a causative agent of LRTI, particularly in 
immunocompromised patients such as those with CF. B. cenocepacia and B. multivorans 
are the most common species isolated from CF patients, whereas B. cepacia is the most 
prevalent isolate in non-CF patients (Hauser et al., 2011; Kenna et al., 2017). Due to 
intrinsic or acquired antibiotic resistance, Bcc is very difficult to eradicate (Rhodes and 
Schweizer, 2016). Varied antibiotic susceptibility is seen between different species, within 
the same species, and between CF and non-CF isolates (Kenna et al., 2017). Factors 
such as efflux pumps, cell wall permeability and remodelling, expression of β-lactamases, 
and altered penicillin binding proteins all contribute to resistance to a large number of 
 16 
antibiotics (Everaert and Coenye, 2016; Nitin Kumar et al., 2017; Malott et al., 2012; 
Podnecky et al., 2015). Antibiotics in clinical use against Burkholderia species infections 
include tobramycin (aminoglycoside), aztreonam and doripenem (β-lactams) (Scoffone et 
al., 2017; Waters et al., 2017). Combination treatments have also been proposed, such 
as moxifloxacin-ceftazidime-colistin, or ceftolozane-tazobactam (El-Halfawy et al., 2017; 
Mazer et al., 2017).  
1.1.3 Polymicrobial biofilm communities in LRTI  
In the natural environment or infection sites, microorganisms rarely exist in monospecies 
communities (Elias and Banin, 2012; Wolcott et al., 2013). There is a growing appreciation 
that bacteria, fungi and viruses co-exist in a polymicrobial biofilm community which is 
defined as a coherent community of multiple microorganisms embedded in a self-
produced matrix adhering on a surface (Hall and Mah, 2017). Abundant evidence has 
shown that pathogens exist within biofilm colonies in the lower respiratory tract of patients 
with COPD, CF and non-CF bronchiectasis (Hassett et al., 2014; Marsh et al., 2014). 
Chronic infections caused by polymicrobial biofilms may eventually lead to the loss of 
pulmonary functions due to recurrent inflammation (LiPuma, 2010; Lynch and Bruce, 2013; 
Surette, 2014).  
To switch from a free-floating mode of growth to a biofilm lifestyle requires environmental 
and genetic triggers as well as precise gene regulation. For example, subinhibitory 
concentrations of clindamycin contribute to upregulation of genes related to the stress 
response, attachment, and extracellular DNA production in S. aureus, and consequently 
lead to increased biofilm formation (Schilcher et al., 2016). Extracellular DNA is extended 
from the surface from active secretion or controlled cell lysis, and plays a critical role in 
attachment, maintaining integrity and protection (Okshevsky and Meyer, 2015). After 
initial attachment, cells in the colony produce an extracellular matrix containing 
exopolysaccharides, extracellular DNA, proteins and lipids (Mann and Wozniak, 2012). 
Subsequently, microbes multiply and mature into a more sophisticated community. Within 
the highly differentiated structure, spatial physiological heterogeneity occurs due to the 
steep gradient of oxygen, nutrients and waste. Compared to the cells in the outer layer, 
cells in the biofilm core are slow growing or even dormant (Wood et al., 2013). Finally, 
under shear stress or environmental factors (for example, antibiotics and immune 
response), microbes escape from the colony and disperse into the environment to find 
new optimal living space, which benefits microbial survival and dissemination (Kaplan, 
2010).  
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Microbes dwelling inside biofilms are phenotypically distinct from their planktonic 
counterparts, and thus they differ in transcriptomes and proteomes (Freiberg et al., 2016; 
Resch et al., 2006). Among them, increased antibiotic resistance in biofilm phenotype 
may be the most important challenge (de Oliveira et al., 2016; Singla et al., 2012). Multiple 
factors contribute to modulating biofilm susceptibility to antibiotics, depending on the 
microbial strains and species, growing conditions, and developmental stage of the biofilm. 
The extracellular matrix confers the first layer of protection. A penetration barrier occurs 
where certain antibiotics such as vancomycin and chloramphenicol have limited 
penetration of Staphylococcal biofilms (Singh et al., 2016). The matrix also contains 
antibiotic-modifying enzymes such as β-lactamases, responsible for degrading β-lactam 
antibiotics (Bowler et al., 2012). Microorganisms are also protected against host response 
by molecules in extracellular matrix. For instance, alginate, the exopolysaccharide present 
in the matrix of P. aeruginosa biofilms, plays an important role in protecting biofilm cells 
from phagocytosis, even in the presence of interferon (IFN)-γ (Leid et al., 2005). 
Molecules responsible for adherence and aggregation in S. epidermidis biofilm matrix 
exhibit an immunomodulatory effect on murine macrophage, through inhibiting NF-κB 
activation and pro-inflammatory cytokine production (Schommer et al., 2011). Of note, 
dispersal of the biofilm structure by gentle ultrasonication without affecting cell viability 
restores phagocytosis and the pro-inflammatory response to S. epidermidis, even though 
dispersed bacteria are still coated with these molecules. This indicates that the secreted 
products in the matrix, as well as intact biofilm architecture, contribute to immune evasion. 
Overall, the matrix confers protection against antibiotic treatment and host defence to all 
the dwellers.  
In addition to the protection by matrix, dormant cells in the core of biofilm remain at low 
growth and metabolic rate as a result of low oxygen, nutrient starvation and high levels of 
waste. Consequently, these cells are less susceptible to antibiotics that target fast-
growing cells (Vandecandelaere et al., 2017; Walters et al., 2003). Additionally, the close 
proximity of cells to each other favours horizontal gene transfer via extracellular DNA or 
conjugation, which facilitates the exchange of multiple mobile genetic elements that may 
contain antibiotic resistance genes (Wintersdorff et al., 2016). In fact, biofilms confer a 
favourable environment as S. aureus biofilms exhibit up to ∼16,000-fold higher frequency 
of conjugation compared to planktonic counterparts (Savage et al., 2013). The 
interactions are in a synergistic or antagonistic manner, and have impact on antibiotic 
resistance (Weigel et al., 2007). For example, in a dual-microbial biofilm model, Moraxella 
catarrhalis confers protection to S. pneumoniae by secreting β-lactamases, and in return, 
S. pneumoniae protects M. catarrhalis in a quorum sensing-independent pathway (Perez 
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et al., 2014). In contrast, antagonistic microbe-microbe interactions also promote 
resistance. P. aeruginosa secretes 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO), which 
suppresses the growth of S. aureus and ultimately reduces S. aureus viability (Orazi and 
O'Toole, 2017). HQNO leads to S. aureus shifting to small-colony variants (SCV) 
phenotype that is commonly associated with slow growing and persistence, whereby it 
promotes S. aureus biofilm resistance to vancomycin and other antibiotics that target 
biosynthesis (Proctor et al., 2006). Thus, polymicrobial interactions within biofilms play a 
critical role in regulating resistance and persistence.  
Apart from the effect on antimicrobial resistance, an antagonistic interaction was observed 
in viability and biofilm formation in a P. aeruginosa and S. aureus co-culture model 
(Baldan et al., 2014). Long-term antistaphylococcal cephalexin treatment reduced S. 
aureus colonisation in infants and young children, whilst accelerated P. aeruginosa 
infection without improving clinical outcomes (Stutman et al., 2002). Notably, S. aureus is 
positively associated with 5-year survival in CF, while P. aeruginosa and Bcc associated 
with increased mortality and morbidity in children younger than 7 years old with CF (Liou 
et al., 2001; Nixon et al., 2001). In addition, P. aeruginosa and Bcc limit the microbiome 
diversity by suppressing the acquisition and persistence of other microorganisms, which 
correlates with worsen pulmonary function (Granchelli et al, 2018; Coburn et al., 2015).  
Polymicrobial infections are also highly resistant to  host immune systems (Bjarnsholt et 
al., 2009). However, due to the complex nature of microbe-microbe and host-microbe 
interactions, the features of host response to polymicrobial infections remain largely 
unclear. Different species seem to work in a cooperative manner inside the host. For 
example, an avirulent oral cavity commensal Streptococcus produces hydrogen peroxide 
(Ramsey and Whiteley, 2009). Once it is sensed by the oral pathogen Aggregatibacter 
actinomycetemcomitans, a genetic response is induced which contributes to the 
production of the complement resistance protein ApiA. As a result, this interaction 
facilitates the survival of both species from the killing by human serum. In addition, 
polymicrobial infections delay wound healing. For example, Dalton et al. (2011) 
transplanted mature biofilms composed of P. aeruginosa, S. aureus, Enterococcus 
faecalis and Finegoldia magna onto a murine chronically-wounded model, and observed 
significantly delayed wound healing at day 8 and increased antimicrobial resistance 
compared to wounds infected with P. aeruginosa.  
Taken together, polymicrobial biofilm infections exhibit increased resistance to antibiotic 
and host defence, and delay wound healing, the net impact of which may lead to a worse 
outcome of patients. Therefore, understanding the mechanisms of host response to 
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polymicrobial infections may shed light on the persistent infections and inefficiency of 
antibiotics and immune clearance, as well as suggest novel clinical treatments.  
1.1.4 Pathogenicity of Staphylococcus aureus  
S. aureus is a commensal yet opportunistic human pathogen, harboured by about 30% of 
individuals (Wertheim et al., 2005). It is frequently isolated from the mucosal surfaces 
(such as nasopharynx, respiratory tract, urinary tract and gastrointestinal tract) and skin 
(van Belkum, 2016). While colonisation has different impacts to the host, it is a known risk 
factor of infections, as about 20% individuals harbor S. aureus persistently and a large 
proportion (60%) of individuals are colonised intermittently (Albrecht et al., 2015; Neha 
Kumar et al., 2015; Williams, 1963). Host symptoms may vary from asymptomatic carriage 
to severe infection, which is largely determined by the host response (Greenberg et al., 
2018; Montgomery et al., 2014). Acquired in hospital and community settings, S. aureus 
is involved in life-threatening infections, including bacteraemia, sepsis, pneumonia, 
wound infections and indwelling device-associated infections (Tong et al., 2015). 
In addition to the rapid evolvement of antibiotic resistance, S. aureus expresses a large 
arsenal of cell wall-anchored and secreted virulence factors to enhance the potential to 
cause infectious diseases (key factors are listed in Table 1.1). Two systematic reviews 
give detailed information on S. aureus virulence factors (Foster et al., 2014; 
Thammavongsa et al., 2015). 
Adherence and internalisation are the prerequisite steps to establish infection. They rely 
on cell wall-anchored virulence factors such as clumping factor A and B (Elkhatib et al., 
2015; Hair et al., 2010; Palmqvist et al., 2004), fibronectin-binding proteins A and B 
(FnBPA and FnBPB) (Foster, 2016), collagen adhesin (Zong et al., 2005), and SpA (Falugi 
et al., 2013; Jung et al., 2001; Pauli et al., 2014), through binding to extracellular matrix 
such as fibrinogen, fibronectin and elastin (Jonsson et al., 1991; Roche et al., 2004; Wann 
et al., 2000). Fibronectin serves as a bridge between αVβ1-integrin on the host side and 
FnBPs on S. aureus surface, and thereby S. aureus enters into non-professional 
phagocytes by endocytosis (Sinha et al., 1999). Mutations in fnbA and fnbB significantly 
reduce renal S. aureus burden and mortality of mice, indicating that both FnBPs are 





Table 1.1 Key immune evasion factors of S. aureus. 
Name Proposed Function Target Reference 
Aureolysin Immune evasion C3 Laarman et al., 2011 
Clumping factor A  Phagocytosis inhibition, 
adhesion  
Fibrinogen, 
complement factor I, 
serum apolipoprotein 
E  
Elkhatib et al., 2015; 
Hair et al., 2010; 
Palmqvist et al., 2004 
Coagulase Phagocytosis inhibition  Fibrinogen Cheng et al., 2010 
Extracellular 
complement-
binding protein  




Complement inhibition  C3d Ricklin et al., 2008 
PSMs  Neutrophil chemotaxis, 
neutrophil lysis 
FPR2 Geiger et al., 2012; 
Kretschmer et al., 
2010; Surewaard et 
al., 2013 
PVL Neutrophil lysis C5aR Genestier et al., 2005; 
Spaan et al., 2013a 
SpA Complement and 
phagocytosis inhibition, 





and Fab, TNFR1, von 
Willebrand factor, 
EGFR 
Dossett et al., 1969; 
Forsgren and Sjoquist, 
1966; Gomez et al., 
2004; 2007; Hartleib 
et al., 2000; Sasso et 
al., 1989  
SSL10 Complement and 
phagocytosis inhibition 
IgG, prothrombin, 
factor Xa, fibrinogen  
Itoh et al., 2010; 2013; 
Patel et al., 2010 
SSL3 TLR2 signalling 
inhibition 
TLR2 Bardoel et al., 2012; 




Complement inhibition  Immunoglobulin, C3 
and factor H 




Complement inhibition  C3 convertase 
(C3bBb)  









The key virulence factor SpA (Figure 1.1) anchors on the cell wall and can be released 
into the extracellular milieu (O'Halloran et al., 2015). While SpA is responsible for immune 
evasion by binding to Fcγ and Fab domains of immunoglobulin (Deisenhofer, 1981; Graille 
et al., 2000), it contributes to pneumonia and inflammation in a murine model by engaging 
with TNFR1 and epidermal growth factor receptor (EGFR) (Gomez et al., 2004; Soong et 
al., 2011). On recognising TNFR1 and EGFR, SpA leads to  activation of RhoA/Rho-
associated protein kinase/ myosin light chain (RhoA/ROCK/MLC), followed by MAPK 
signalling and calpain activity in human airway epithelial cells (Soong et al., 2011). The 
cysteine protease calpains cleave junctional proteins occludin and E-cadherin (Chun and 
Prince, 2009), and thereby allow S. aureus and neutrophil penetration across airway 
epithelial cell monolayers through the paracellular junctions. However, in mice infected 
with S. aureus intranasally, calpain inhibitor but not EGFR inhibitor, increases 
Staphylococcal load, which indicates that SpA requires activation of EFGR and TNFR1 
as well as proteolytic activity to invade airway epithelial barriers in vivo. Of interest, a later 
paper published shows that the S. aureus load is the same in Tnfr1-/- mice as in wild type 
mice (Ahn et al., 2014). An experiment that blocks both TNFR1 and EGFR should be done 
to confirm both receptors are critical for Staphylococcal invasion. Moreover, SpA seems 
to rely on TNFR1, EGFR and Fas ligands to induce IL-16  secretion in cluster of 
differentiation (CD)-4+ cells, which is mediated by Ca2+ flux and calpain activity (Ahn et al., 
2014). Of note, neutralising IL-16 augments phagocytosis and alleviates tissue damage 
without affecting phagocyte influx, and thus IL-16 promotes pneumonia and excessive 
inflammation in SpA-mediated infections. Overall, due to a wide range of virulence factors, 
S. aureus is able to shift from innocuous colonisation to pathogenic infections; therefore, 




Figure 1.1 SpA targets and downstream host signalling. 
(A) SpA can be recognised by multiple host receptors and modulate host signalling cascades in 
airway epithelial cells and CD4+ cells, as described in Gomez at al., 2004; Soong et al., 2011; Ahn 
et al., 2014.  
(B) Known signalling cascades in airway epithelial cells (Gomez and Prince, 2008). 
Own original artwork. 
 
Neutrophils are a major component in host defence against S. aureus and one of the first 
responders recruited to the site of infection. The migration of neutrophils, namely 
chemotaxis, relies on sensing the gradient of chemoattractant (Li Jeon et al., 2002) and 
adhesive interactions between endothelium receptors and neutrophil ligands (Choi et al., 
2009). S. aureus possesses a wide range of ligands that bind to neutrophil surface 
receptors and disturb cellular homeostasis (Figure 1.2). For example, highly virulent 
community acquired-MRSA isolates express amphipathic phenol-soluble modulins 
(PSMs, Table 1.1) which recognise formyl peptide receptor (FPR)-2 on neutrophils 
(Kretschmer et al., 2010). PSMs elicit a robust pro-inflammatory response as well as 
neutrophil chemotaxis and subsequently lyse neutrophils. In contrast, S. aureus interferes 
with FPR in the opposite way. Staphylococcal FPR2-inhibitory protein (FLIPr) and its 
homologue FLIPr-like (FLIPrL) block FPRs and therefore subvert the neutrophil response 
to FPR agonists (Prat et al., 2006; 2009). Additionally, chemotaxis inhibitory protein of S. 
aureus blocks FPR1 and neutrophil complement receptor C5aR (de Haas et al., 2004). 
To hinder chemotaxis, Staphylococcal superantigen-like proteins 5 and 11 (SSL5 and 
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SSL11) recognise P-selectin glycoprotein ligand (PSGL-1) on neutrophils and 
consequently, disturb the interaction between PSGL-1 and P-selectin on endothelial cells 
(Bestebroer et al., 2007; Chung et al., 2007). Additionally, SSL3 (Table 1.1) binds to Toll-
like receptor (TLR)-2 heterodimers and thereby inhibits TLR2-mediated pro-inflammatory 
response induced by Staphylococcal lipoteichoic acid and lipopeptides (Bardoel et al., 
2012; Yokoyama et al., 2012). Staphopain and SSL10 (Table 1.1) target C-X-C 
chemokine receptor 2 and 4 (CXCR2 and CXCR4) respectively (Laarman et al., 2012; 
Walenkamp et al., 2009), which are critical for neutrophil activation and chemotaxis from 
the bone marrow (C. Martin et al., 2003). Furthermore, S. aureus promotes neutrophil 
lysis through secreting bicomponent pore-forming toxins which bind to the leucocyte 
membrane and form β-barrel pores that span the lipid bilayer (Alonzo and Torres, 2014; 
Spaan et al., 2017). Leucocidins consist of LukAB/HG, LukED, γ-haemolysin AB (HlgAB), 
γ-haemolysin CB (HlgCB) and Panton-Valentine Leucocidin (PVL, Table 1.1). LukAB/HG 
binds to CD11b subunit of the αMβ2 integrin on neutrophils (DuMont et al., 2013), and 
LukED binds to CXCR1 and CXCR2 on neutrophils and C-C chemokine receptor type 5 
(CCR5) on T cells, macrophages and DCs (Alonzo et al., 2013; Reyes-Robles et al., 2013). 
HlgAB targets chemokine receptors including CXCR1, CXCR2 and CCR2, whereas 
HlgCB targets complement receptors C5aR and C5L2 (Spaan et al., 2014). Lastly, 
frequently exhibited in community acquired-MRSA isolates, PVL recognises C5aR and 
C5L2 (Spaan et al., 2013a). In addition to inhibiting neutrophil chemotaxis and 
complement activation, leucocidins (LukED and HlgAB) disrupt the erythrocyte membrane 
to sequester iron, and thereby acquire essential nutrients for proliferation inside the host 
(Spaan et al., 2015).  
 
 
Figure 1.2 Staphylococcal inhibition of neutrophil activation and chemotaxis. 
S. aureus subverts neutrophil extravasation and chemotaxis with multiple antagonists (yellow 
boxes) targeting neutrophil receptors (own original artwork). 
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Apart from SpA, S. aureus evades complement attack using other virulence factors. First, 
Gram-positive bacteria are protected by a much thicker peptidoglycan layer (20 nm) 
compared to Gram-negative bacteria (2.5 nm), which confers protection from membrane 
attack complex-mediated killing (Joiner et al., 1984). Capsular polysaccharides are 
reported to play an important role in evading opsonophagocytosis (Luong and Lee, 2002; 
Thakker et al., 1998; Nanra et al., 2013). Staphylococcal complement inhibitor recognises 
and blocks C3 convertases, which regulate all three complement activation pathways 
(Rooijakkers et al., 2005). Its homologues extracellular fibrinogen-binding protein and 
extracellular complement-binding protein (Table 1.1) bind to C3d and consequently inhibit 
C3 and C5 convertases (Hammel et al., 2007b; Jongerius et al., 2010a; Jongerius et al., 
2007).  
The fates of intracellular S. aureus and the infected host cells are determined by the host 
cell types, the isolates and the ratio of S. aureus to host cells (multiplicity of infection, MOI) 
(Kubica et al., 2008; Strobel et al., 2016). Following internalisation, S. aureus are rapidly 
engulfed into endosomes (in non-professional phagocytes such as epithelial cells, 
endothelial cells and fibroblasts) or phagosomes (in professional phagocytes such as 
neutrophils, macrophages and monocytes), which are intracellular compartments derived 
from the plasma membrane (Chi et al., 2014). Endosomes and phagosomes fuse with 
vacuoles and initiate the degradation of intracellular bacteria with proteases (Pillay et al., 
2002), antimicrobial peptides (Rosenberger et al., 2004), reactive oxygen species (ROS) 
and reactive nitric species (RNS) (Fang, 2004), and are highly acidic (Hamaguchi et al., 
2014). Nevertheless, S. aureus has the ability to survive in the hostile environment, 
escape into the cytoplasm and manipulate host cell programmed cell death.  
To subvert lysozyme degradation of the cell wall peptidoglycan, S. aureus produces 
neutrophil serine protease inhibitors (Stapels et al., 2014). To reduce susceptibility to 
antimicrobial peptides, S. aureus exploits two distinct mechanisms. Due to the commonly 
cationic nature of antimicrobial peptides, the first tactic is to modify membrane lipids, 
which results in reduced negative membrane surface charge (Peschel et al., 2001; 1999). 
In addition, S. aureus secretes proteases including aureolysin and staphylokinase, which 
cleaves cathelicidin LL-37 and neutralises α-defensin, respectively (Jin et al., 2004; 
Sieprawska-Lupa et al., 2004).  
S. aureus secrets antioxidants such as the carotenoid pigment staphyloxanthin, 
superoxide dismutase, Staphylococcal peroxidase inhibitor, catalase, and L-lactate 
dehydrogenase to reduce oxidative stress or nitrosative stress (Clauditz et al., 2006; de 
Jong et al., 2017; Gaupp et al., 2012; Mandell, 1975; Richardson et al., 2008). α toxin 
contributes to resistance towards oxidative burst through disengaging the close proximity 
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of internalised S. aureus to mitochondria in macrophages, and thereby protects 
themselves from mitochondrial ROS, caspase-1 and the antimicrobial metabolite 
fumarate (Cohen et al., 2018).  
Despite phagosome pH being as low as 4 (Cachat et al., 2015), the pH lethal for S. aureus 
is 2 in vitro (Chan et al., 1998). In contrast to Gram-negative bacteria such as E. coli, 
phagocytosis and phagosome acidification play critical role in TLR-mediated responses 
by S. aureus (Ip et al., 2010). Unlike other MRSA and methicillin-sensitive S. aureus 
(MSSA) isolates, the highly virulent MRSA USA300 is able to survive in macrophage 
phagosome at pH 5 (Tranchemontagne et al., 2016). The increased virulence of USA300 
is correlated with increased expression of regulatory elements including agr, sarA, and 
saeRS (Montgomery et al., 2008; Wang et al., 2007). The resistance of USA300 to 
phagocytosis appears to be triggered by acidification and other environmental cues in the 
phagosome, which leads to upregulation of agr gene locus expression (Tranchemontagne 
et al., 2016).  
As part of the antimicrobial response, host cells initiate apoptosis once infected with 
bacteria and are subsequently engulfed by macrophages. Compared to other modes of 
cell death, apoptosis is preferable and non-inflammatory through multiple mechanisms 
(Szondy et al., 2017). However, S. aureus either evades apoptosis through EsxA, a 
substrate of ESAT-6-like secretion system or switches to necrosis in an agr-dependent 
manner (Korea et al., 2014; van Krüchten et al., 2018). In contrast to apoptosis, necrosis 
involves the disruption of the plasma membrane and release of cellular contents. Thus, it 
is highly pro-inflammatory and detrimental to the host, leading to tissue damage (Edinger 
and Thompson, 2004).  
Taken together, the opportunistic pathogen S. aureus is capable of shifting from 
commensal to pathogenic and fully equipped with a plethora of virulence factors to survive 
and persist in the host.  
1.1.5 Pathogenesis of Bcc 
As mentioned above, Bcc species are opportunistic pathogens that mainly affect 
immunocompromised groups such as CF patients, and one of the major challenges is its 
intrinsic antibiotic resistance. The clinical manifestations of Burkholderia colonisation can 
vary greatly and is unpredictable. Whilst some patients exhibit asymptomatic chronic 
infection, about 20% of patients have a life-threatening exacerbation of respiratory 
function among CF and non-CF patients (Isles et al., 1984; Hauser and Orsini, 2015). The 
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‘cepacia syndrome’ is characterised by pyrexia, rapidly progressive pulmonary function 
decline, sepsis and bacteraemia.  
Although only a small proportion of CF individuals (2.7%) are colonised by Bcc, the 
acquisition is a major concern among CF patients, their caregivers and families. It has 
been acknowledged since the 1980s that certain epidemic  strains (for example the ET12 
clone and PHDC strain of B. cenocepacia) are highly transmissible among patients and 
even from patients to non-CF individuals (LiPuma et al., 1988; Govan et al., 1993; Holmes 
et al., 1999). Thus, a strict cohort segregation for CF patients harbouring Bcc was 
implemented worldwide; however, it caused fear and loneliness to worsen the 
psychological conditions of these individuals (Duff, 2002). Due to the strict infection control 
measures, the new acquisition of B. cenocepacia dropped dramatically after 1995 and B. 
cenocepacia became less predominant among CF individuals (LiPuma, 2010; Zlosnik et 
al., 2015). Survival analysis reveals that patients colonised with B. cenocepacia have a 
significantly worse outcome compared to B. multivorans (Zlosnik et al., 2015).  
Nevertheless, new acquisition of Bcc still occurs in spite of segregation practice. In 
Queensland, Australia, 75% new cases of the total incidence of Bcc colonisation occurred 
during in the period 2001-2011. The isolates reveal high genetic diversity and the majority 
of patients (85%) are associated with unique strains (Ramsay et al., 2013). This indicates 
the sporadic acquisition of Bcc from independent sources in the post-segregation period, 
most likely from the environment and can be affected by environmental factors such as 
the amount of rainfall (Peddayelachagiri et al., 2016; Ramsay et al., 2013).  
Bcc species are known to breach the epithelial barrier, leading to bacteraemia, as well as 
trigger an exacerbated proinflammatory response (Downey et al., 2007; McClean and 
Callaghan, 2009; Saldias and Valvano, 2009). Moreover, Bcc is capable of survival within 
bronchial epithelial cells and professional phagocytes or mucus extracellularly in the 
lumen (Schwab et al., 2014). Intracellular B. cenocepacia J2315 (ET12 clone) is 
sequestered in B. cenocepacia-containing vacuoles that are fused with early endosomes. 
In contrast to heat-inactivated bacteria, which are rapidly degraded in the phagolysosome, 
live bacteria subvert the phagocytic pathway by delaying phagosomal maturation and 
fusion with the lysosome by up to 6 h, and thereby maintaining the vacuole at pH 6.4 
(Lamothe et al., 2007).  
Furthermore, the assembly of Nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase complex on live B. cenocepacia-containing vacuoles is delayed compared to 
heat-inactivated B. cenocepacia (Keith et al., 2009). NADPH oxidase contributes to ROS 
by producing the precursor superoxide. This results from the manipulation of Rho family 
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GTPases by type VI secretion system (T6SS)-derived effectors (Table 1.2) (Rosales-
Reyes et al., 2012b). Morphology alteration is observed in murine macrophages by live B. 
cenocepacia, which involves deactivation of Rho GTPases in a T6SS-dependent manner 
(Flannagan et al., 2012; Rosales-Reyes et al., 2012b). The T6SS-derived effector TecA 
deamidates Rho GTPases and leads to cytoskeleton disruption and inflammation (Aubert 
et al., 2016).  
While it has been shown that Bcc species readily form strong biofilms in vitro (Caraher et 
al., 2007; Scoffone et al., 2016), Schwab et al. (2014) have reported that only single 
bacteria or small clusters are observed either in phagocytes or mucus in bronchial 
sections from CF lung tissues. This may indicate that biofilm formation is not a virulence 
factor associated with B. cenocepacia infections.  
To facilitate motility and  invasion, Bcc is equipped with whip-like polar flagella (Table 1.2) 
(Tomich et al., 2002). The flagellin filament of flagella is specifically recognised by TLR5 
and the major ligand that induces a pro-inflammatory response in airway epithelial cells 
(de C Ventura et al., 2008; Hayashi et al., 2001). Consequently, blocking the association 
between flagellin and TLR5 improves lung injury in CF (Blohmke et al., 2008).   
Another major virulence factor, lipopolysaccharide (LPS, Table 1.2) can activate TLR4, 
leading to a cytokine/chemokine response through activation of MAPK and NF-κB 
(Bamford et al., 2007). Compared to other Gram-negative bacteria, Bcc LPS has unique 
properties and confers protection against antibiotics and antimicrobial peptides (Loutet et 
al., 2006; 2010; Vinion-Dubiel and Goldberg, 2003). The positively charged 4-amino-4-
deoxy-arabinose is present in the lipid A and core oligosaccharide, which neutralises the 
anionic charge of phosphate residues in LPS (De Soyza et al., 2008). Consequently, 4-
amino-4-deoxy-arabinose contributes at least partially to the resistance to cationic 
antibiotics and antimicrobial peptides (Hamad et al., 2012; Scott et al., 1999).  
In addition, clinical Bcc isolates are commonly coated extracellular by mucoid 
exopolysaccharide (Table 1.2) (Herasimenka et al., 2007). Exopolysaccharide are 
associated with chronicity, and confer protection by inhibiting neutrophil chemotaxis and 
production of ROS, as well as scavenging ROS (Bylund et al., 2006). However, CF 
individuals exclusively infected with nonmucoid isolates (such as B. cenocepacia J2315) 
is correlated with a faster rate of lung function decline compared to patients infected with 
mucoid Bcc (Zlosnik et al., 2011). 
Taken together, Bcc species are highly virulent and readily to adapt from natural 
environment to dwell inside the human host with the assistance of a wide range of 
virulence factors.  
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Table 1.2 Key virulence factors of Bcc 
Virulence factors Functions Reference 
Cable pili and the 22-
kDa adhesin 
Targeting cytokeratin 13 and 
transmigration across the airway 
epithelium, inflammation 
Urban et al., 2005; 
Goldberg et al., 2011 
Exopolysaccharides Phagocytosis inhibition, chemotaxis 
inhibition, ROS inhibition 
Bylund et al., 2006; 
Conway et al., 2004 
Flagella Motility, adhesion and invasion, and 
inflammation 
Tomich et al., 2002; 
Urban et al., 2004 
LPS Inflammation, intrinsic 
antibiotic/antimicrobial peptides 
resistance and phagocytosis inhibition 
Silipo et al., 2007; Loutet 
et al., 2006; Vinion-
Dubiel and Goldberg, 




Adhesion and inflammation Dennehy et al., 2017 
Quorum sensing Regulation of the expression of 
siderophore, zinc metalloproteases, 
swarming motility and biofilm formation 
Lewenza et al., 1999; 
Huber et al., 2001; Kooi 
et al., 200 
RpoE Phagocytosis inhibition, stress response 
regulator, and polymyxin B resistance 
Flannagan and Valvano, 
2008 
RpoN Phagocytosis inhibition, biofilm formation, 
motility, nitrogen metabolism and 
exopolysaccharide synthesis 
Saldias et al., 2008; Fazli 
et al., 2017; Lardi et al., 
2015; Liu et al., 2017 
Siderophores and 
FtrBccABCD 
Iron uptake Mathew et al., 2014; 
Thomas, 2007 
T6SS  Actin cytoskeleton disruption, 
phagocytosis inhibition, delaying NADPH 
oxidase complex assembly, regulation of 
T2SS 
Flannagan et al., 2012; 
Rosales-Reyes et al., 
2012a; Rosales-Reyes 
et al., 2012b 
Type IV secretion 
system  
Intracellular survival and replication Sajjan et al., 2008 
Zinc metalloproteases  Degrading extracellular matrix (type IV 
collagen, fibronectin), neutrophil protease 
inhibitor, macroglobulin, and antimicrobial 
peptides  
Kooi et al., 2005; Kooi et 









 Microbial recognition by the innate immune system and host response 
The respiratory tract is the second largest mucosal surface in human body and is 
constantly exposed to the outer environment. It is anatomically divided into the upper 
airways, the lower airways (the trachea and bronchi) and alveoli (Patwa and Shah, 2015). 
The major role of the respiratory system is gas exchange, which occurs at the alveolar-
capillary membrane. The blood-air barrier is extremely thin (average thickness of normal 
lungs, 1.7 μm) to maximise oxygen diffusion (Divertie et al., 1975). The average volume 
of gas inhaled into a person’s lungs (respiratory minute volume) at rest is about 6 litre/min. 
Inevitably, small particles and microbes are ventilated into the conducting tract with air, 
which results in the respiratory system being a favourable entrance for pathogens. Thus, 
in order to provide warm, hydrated and almost sterile air to the peripheral alveoli, the 
conducting airways are delicately designed with multiple physical and chemical barriers. 
True threats must be quickly detected and removed, but unnecessary inflammatory 
responses should be avoided. Hence, the threshold of sensitivity is critical for normal 
respiratory functions; otherwise the airway is constantly hyper-responsive and chronically 
inflamed, causing diseases such as asthma and COPD. Hence, apart from mounting 
effective immune responses, the respiratory tract is tightly regulated to minimise 
unfavourable tissue damage and maintain homeostasis of the respiratory system.  
1.2.1 Cells of the innate immune system in the airway 
Individual cells types shape and orchestrate the innate immunity. From trachea to terminal 
alveoli, the conducting airways are predominantly lined with epithelial cells. The mucosa 
and, directly beneath, the epithelium compartment also contain professional immune cells, 
including DCs, macrophages, monocytes, neutrophils and mast cells (Yu et al., 2016). 
These cells serve a surveillance role and are regulated by airway epithelial cells.  
1.2.1.1 The multifaceted roles of airway epithelium as the first line of host 
defence 
As the first cell type that comes into contact with environmental agents, the epithelium 
performs a central role in surveillance, protection and immune regulation (Whitsett and 
Alenghat, 2015; Weitnauer et al., 2016). The composition and morphology of epithelia 
vary from distal to proximal. Ciliated pseudostratified epithelia, goblet cells, 
undifferentiated columnar cells and basal cells constitute the epithelium in the large 
airways (0 to 5th division), while in small airways (6th to 23rd division) having the same 
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composition, ciliated epithelia and goblet cells are gradually replaced by club cells (Crystal 
et al., 2008). The gas exchange chamber alveoli are mainly composed of alveolar type I 
and type II cells. Squamous type I cells are thin and in close proximity to endothelial cells 
of respiratory capillaries, covering approximately 95% of the surface areas (Crapo et al., 
1982; Weibel, 2015). Cuboidal type II cells are critical for producing surfactant lipids and 
proteins, as well as being the precursors of type I cells during repair (Barkauskas et al., 
2013).  
The epithelium (Figure 1.3) in the conducting airways is coated with a thin layer of mucus 
produced by goblet cells and submucosal glands cells (Ballard and Inglis, 2004; Ma et al., 
2018). Normal mucus is a low viscous yet elastic fluid, containing water (about 98%), 
mucins, proteins, lipids, salts and cell debris (Fahy and Dickey, 2010). Inhaled particles 
are trapped by mucus, thereby being transported promptly to the pharynx by coordinated 
cilia beating (Kilburn, 1968). This process is a critical innate defence mechanism, namely 
mucociliary clearance (MCC). Defects in MCC caused by mucus hyperproduction will 
result in mucus plugs and entrapped microbial substances, which eventually result in 
pathological conditions, such as COPD, asthma and bronchiectasis (Evans et al., 2009; 
Ramos et al., 2014; Sears et al., 2015). In addition, the mucus layer restricts the direct 
contact between microbial substances and airway epithelial cells, which prevents 
unnecessary inflammatory responses.  
Beneath the mucus layer, airway epithelium and apical junctional complexes form a 
physical barrier against potential pathogenic threats, controlling paracellular transport, 
and establishing cell polarity. This barrier is a key component of respiratory tract 
homeostasis as it limits the access of inflammatory ligands to subepithelial professional 
immune cells. Cell-cell adhesion is built up with the apical tight junctions and underlying 
adherens junctions (Georas and Rezaee, 2014). While the extracellular loops of tight 
junction proteins bind to their counterparts on the adjacent cells, the cytoplasmic domains 
are connected to the actin cytoskeleton by Zonula occludens-1 (Hartsock and Nelson, 
2008). Tight junctions are positively or negatively regulated by different factors, such as 
Zonula occludens-1 exchange, TLR ligands, microbial infection (Kojima et al., 2013; 
Ragupathy et al., 2014; Yu et al., 2010). Adherens junctions contain transmembrane 
nectins and E-cadherin, the latter binding to catenins. Modulation of β-catenin affects the 
expression of E-cadherin, and thereby affects the morphology, differentiation of epithelial 




Figure 1.3 Schematic of the conducting airway and alveolus. 
The conducting airway is composed of ciliated epithelial cells and secretory cells, while the gas 
exchange chamber alveolus is composed of type I and II alveolar cells. The airway is lined with a 
periciliary layer and a mucus layer which are responsible for antigen removal cooperating with cilia 
beating. The alveolus is coated with surfactant which reduces surface tension and has 
immunomodulatory effects. Under steady state, professional immune cells such as DCs, T cells, 
and macrophages reside within the respiratory system or in the interstitial space to perform a 
surveillance role. Upon activation, macrophages and DCs engulf infectious stimuli and present 
antigen to T cells. Adapted from Fahy and Dickey (2010), and Hussell and Bell (2014).  
 
Airway epithelial cells, secretory cells, and professional immune cells locally produce RNS, 
surfactants, antimicrobial peptides, and complement products, which are multi-functional 
components of host defence. These antimicrobial products are described below. 
The free radical nitric oxide has bacterial killing effect in the airway surface fluid at 
physiologic concentration (Workman et al., 2017). In addition, nitric oxide is a messenger 
regulating airway smooth muscle relaxation and cilia beating frequency, thereby 
promoting MCC (Venugopalan et al., 1998; Stout et al., 2007).  
Surfactants lipids and proteins are important for normal function and physiology of the 
respiratory system through reducing alveolar surface tension during respiratory cycle 
(Whitsett et al., 2010). Moreover, surfactants recognise microbial ligands, C1q, TLRs and 
their co-receptors, thereby promoting opsonisation and phagocytosis, as well as anti-
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inflammatory responses (Ariki et al., 2012; Watford et al., 2001). Alveolar type II cells are 
the major sources of surfactants; club cells have also been reported to produce 
surfactants (Calkovska et al., 2015).  
Antimicrobial peptides are constitutively produced or induced upon infection. Defensins 
are small cationic molecules (3-5 kDa) and divided into 2 subgroups, α-defensins and β-
defensins (hBDs). In airway epithelial cells, hBD-1 is constitutively expressed and not 
inducible under inflammatory conditions, whereas hBD-2 expression is only induced by 
inflammatory stimuli (Kao et al., 2004; Singh et al., 1998). Apart from an antimicrobial 
effect, hBD-3 is a chemoattractant for macrophage and works synergistically with LL-37 
(Abou Alaiwa et al., 2014; García et al., 2001). Furthermore, lysozyme degrades 
peptidoglycan in Gram-positive bacteria cell wall, and thus is less effective on Gram-
negative bacteria (Nash et al., 2006). Lysozyme has synergistic effects with lactoferrin 
and secretory leucocyte protease inhibitor (SPLI) (Singh et al., 2000). In addition to iron 
sequestering, lactoferrin impairs biofilm formation, bacterial adhesion, and has 
immunomodulatory effects (Jahani et al., 2015; Singh, 2004; Siqueiros-Cendon et al., 
2014). The antiprotease activity of SPLI protects the epithelium from neutrophil elastase 
under inflammatory conditions (Hiemstra, 2002).  
Lastly, the complement system is activated in response to environmental stimuli in the 
airway epithelium (Kulkarni et al., 2018). Complement has diverse immunomodulatory 
functions, including enhancing phagocytosis, connecting the innate and adaptive 
immunity and regulating homeostasis (Hajishengallis et al., 2017). For example, the level 
of C3a in sputum isolated from CF individuals is positively correlated with the lung function 
(Sass et al., 2015). This may due to C3a inhibition on neutrophil recruitment and activity 
(Shinjyo et al., 2009). 
When the amount of foreign antigens in the conducting airways exceeds a certain 
threshold, to accurately and rapidly recognise invading stimuli, the airway epithelium is 
equipped with pattern recognition receptors (PRR), which will be described in 1.2.2. 
Activation of PRR signalling by pathogen associated molecular patterns (PAMP) results 
in expression of pro-inflammatory cytokines/chemokines, which amplifies the host 
response such as promoting phagocytosis. Inevitably, antimicrobial mechanisms such as 
oxidative burst and release of lytic enzymes cause respiratory tissue damage. Therefore, 
in order to avoid unnecessary damage under homeostatic conditions, the epithelium uses 
distinct strategies to adjust sensitivity, including secretion of anti-inflammatory molecules, 
regulating the expression level and asymmetrical expression of PRRs on polarised 
mucosal barrier. 
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As a consequence of low or absent expression of TLR2, TLR4, and their co-receptors 
CD36, CD14, and MD-2, airway epithelial cells fail to initiate a strong pro-inflammatory 
response to TLR2 and TLR4 ligands (Becker et al., 2000; Ioannidis et al., 2013; Jia et al., 
2004; Mayer et al., 2007). The cellular localisation, together with the expression level of 
TLRs regulate ligand accessibility and tolerance. Asymmetric expression of TLRs on the 
apical and basolateral surface has been observed in airway epithelium (Ioannidis et al., 
2013). Thus, the restricted access to the sensors on the basolateral surface by 
paracellular junctions only allows incoming pathogens to activate TLRs when they breach 
the barrier (Humlicek et al., 2007). From bronchi to alveoli, TLR5 expression is shifted 
from the basolateral to the apical surface, which is correlated with the level of sterility in 
different parts of the respiratory tract (Shikhagaie et al., 2014). The activation threshold of 
airway epithelium can be adjusted by pre-exposing to certain stimuli such as respiratory 
syncytial virus (Monick et al., 2003) or cigarette smoke (Pace et al., 2008), which 
upregulate the expression and membrane localisation of TLR4, and thereby sensitise 
airway epithelial cells in response to LPS. 
Overall, as a central regulator in host defence, the airway epithelium plays multiple roles 
to maintain the normal physiology of respiratory system, including barrier function and 
MCC, secreting antimicrobial and immunomodulatory molecules into the airway surface 
fluid, surveillance and quickly initiating host defence in cooperation with professional 
immune cells against infectious agents.     
1.2.1.2 The roles of macrophages in host defence against airway infections 
Macrophages resident in the lungs at steady state can be divided into interstitial 
macrophages and alveolar macrophages (Lehnert et al., 1985). Interstitial macrophages 
can be found in the space between alveolar cells and capillary endothelial cells, while 
alveolar macrophages are located on the luminal side of alveoli (Figure 1.3). Compared 
to alveolar macrophages, interstitial macrophages have higher turnover rate, and higher 
capacity of producing cytokines in response to IFN-γ and LPS (Cai et al., 2014). Interstitial 
macrophages also contribute to homeostasis by generating IL-10 and inhibiting DCs 
activity (Bedoret et al., 2009).  
Alveolar macrophages serve as sentinels and regulators, due to their phagocytic capacity, 
expression of PRRs, and ability to generate cytokines and chemokines (Kopf et al., 2015). 
Under homeostatic conditions, alveolar macrophages mediate the tolerance threshold to 
harmless exogenous antigens (Thepen et al., 1989). The immunomodulatory factors 
generated by alveolar macrophages directly suppress T cells, include prostaglandins 
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(Pica et al., 1996; Ruggeri et al., 2000), nitric oxide (Bingisser et al., 1998), IL-10 (Mittal 
et al., 2015), and TGF-β (Yoshimura and Muto, 2011). Alveolar macrophages appear to 
directly inhibit antigen presentation and migration of DCs (Holt et al., 1993; Jakubzick et 
al., 2006). By competitively engulfing incoming antigens, alveolar macrophages limit the 
antigen uptake by DCs and thereby block DCs antigen presentation to T cells 
(Archambaud et al., 2010).  
Alveolar macrophages are in close proximity to the alveolar lumen, and hence their activity 
is tightly regulated by ligands on the surface of epithelial cells (Hussell and Bell, 2014). 
By cell-cell interactions, latent TGF-β binds to αVβ6-integrin on airway epithelial cells and 
is subsequently transformed into bioactive TGF-β, which suppresses the expression of 
cytokines in alveolar macrophages (Sheppard, 2006).  However, once activated, alveolar 
macrophages interrupt the cell-cell interactions and thus the brake on cytokine production 
by TGF-β is released (Morris et al., 2003). In addition, signal-regulatory protein-α, 
mannose receptor, and CD200 also negatively regulate alveolar macrophages function 
(Hussell and Bell, 2014; Snelgrove et al., 2008; Zhang et al., 2004).  
Once the negative signalling is overridden by infectious agents, alveolar macrophages 
switch from a tolerogenic mode to inflammatory mode, exhibiting higher phagocytic ability, 
higher oxidative burst, and stronger expression of pro-inflammatory cytokines. Neutrophils 
and monocytes are recruited by the signals released from alveolar macrophages (Nomura 
et al., 2001). To prevent dissemination, alveolar macrophages rapidly engulf apoptotic 
epithelial cells and apoptotic neutrophils (Rubins, 2003; Grabiec and Hussell, 2016). This 
process protects the host from toxic products leaked from neutrophils. Once the 
inflammatory response is unleashed, the outcome depends on the interactions between 
virulence factors of pathogens and the corresponding host response. Hence, alveolar 
macrophages serve as a gatekeeper of inflammatory responses in the alveoli.     
1.2.1.3 The roles of neutrophils in airway infections 
Neutrophils are generated from the bone marrow and circulating in the bloodstream. 
When infection occurs, airway epithelial cells and alveolar macrophages release 
inflammatory mediators (such as IL-8, IFNs, C3a, and C5a) and neutrophils respond to 
the call. Upon interactions between endothelial receptors and the ligands on neutrophils, 
neutrophils migrate to the site of infection following the concentration gradient of 
chemoattractants (Thammavongsa et al., 2015).   
Once recruited to the battlefield, neutrophils rapidly engulf opsonised bacteria and 
challenge them with various toxic products in the granules, including antimicrobial 
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peptides, ROS, nitric oxide, and proteolytic enzymes (van Kessel et al., 2014). Upon 
phagocytosis, neutrophils initiate apoptosis and release ‘eat me’ signals 
(phosphatidylserine) to macrophages, to put a brake on excessive inflammatory 
responses (Fox et al., 2010). In addition, neutrophils immobilise and kill extracellular 
bacteria by releasing neutrophil extracellular traps which contains DNA and antimicrobial 
peptides (Spaan et al., 2013b).  
However, the bactericidal activity of neutrophils is equally harmful to the host if out of 
control. Therefore, in the resolving phase, negative regulators (such as the sialic acid 
binding Ig-like lectin E, and NADPH oxidase) and macrophage phagocytosis are important 
to eliminate neutrophils in due course (Davidson et al., 2013; McMillan et al., 2013; Kruger 
et al., 2015). Prolonged neutrophil presence leads to chronic inflammation, tissue injury, 
and delayed healing; diseases such as COPD, CF, asthma, and pulmonary fibrosis are 
associated with the failure to remove apoptotic neutrophils (Hodge et al., 2003; Morimoto 
et al., 2012; Vandivier et al., 2002).  
Overall, neutrophils play a key role in first line defence but require tight regulation to 
prevent the detrimental effect on the host. 
1.2.2 TLR-mediated pathogen recognition and host defence 
1.2.2.1 Overview of PRRs 
The sentinels of the lower respiratory system, airway epithelial cells and respiratory-
resident phagocytes express a wide range of conserved PRRs to detect exogenous 
PAMPs and endogenous damage-associated molecular patterns, as well as modulate 
efficient immune responses. PRRs include TLRs, nucleotide-binding oligomerization 
domain-like receptors (NLRs), C-type lectins, and retinoid acid-inducible gene-I receptors 
(RLRs) (Takeuchi and Akira, 2010). Located in the cytoplasm, NLRs recognise bacterial 
ligands (peptidoglycan, flagellin), viral RNA, and fungi, leading to activation of MAPK and 
NF-κB signalling, inflammasome formation, and type I IFNs production (Kim et al., 2016). 
C-type lectins binds a wide range of carbohydrates ligands from fungi, bacteria, and 
viruses (Hoving et al., 2014). Activation of C-type lectins leads to activation of transcription 
factors, phagocytosis, and the development of T helper 1 and T helper 17 responses 
(Hardison and Brown, 2012). RLRs recognises intracellular viral double-stranded RNA, 
following by activation of IFN regulatory factor (IRF)-3 and NF-κB, and ultimately leads to 
production of IFN-β and antiviral immune responses (Matsumiya and Stafforini, 2010). All 
PRRs play a key role in sensing exogenous antigens and rapidly initiating the host 
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response to remove the incoming threats and keeping damage under control. To maintain 
the homeostasis, PRRs are required to discriminate between self/non-self, 
commensal/pathogenic antigens, and exhibit tolerance under certain threshold. In the 
following section, the first discovered PRRs, TLRs, and their interactions with PAMPs will 
be the focus. 
1.2.2.2 Overview of TLRs 
The discovery of TLRs in the 1990s was of significant importance to the field of innate 
immunity and was recognised by awarding the 2011 Nobel Prize in Physiology or 
Medicine to Bruce Beutler and Jules Hoffmann. TLRs are the key molecules in 
surveillance, signalling transduction and ultimately induction of immune responses. Their 
dysfunction is associated with allergic inflammation (Clarke et al., 2014), chronic 
inflammation, tumorigenesis (Korneev et al., 2017), and autoimmune diseases 
(Mohammad Hosseini et al., 2015). 
So far there have been 10 TLRs (Table 1.3) identified in humans, with each one 
recognising unique ligands from bacteria, viruses, and fungi. TLRs are widely expressed 
in leukocytes and non-immune cells (including mucosal epithelial cells, fibroblasts, and 
endothelial cells), and their expression is regulated by microbial stimuli and cytokines 
(McClure and Massari, 2014; Zarember and Godowski, 2002). TLR1, 2, 4-6 are primary 
transmembrane receptors that sense extracellular antigens, whereas TLR3, 7-10 are 
expressed on the membrane of endoplasmic reticulum (steady-state) and trafficking to 
endolytic compartments (active-state) to engage with internalised viral ligands. Despite 
recognising structurally distinct ligands, TLRs share common a architecture. The ligand-
binding ectodomain contains leucine-rich repeats, while the cytoplasmic domain contains 
Toll/IL-1 receptor (TIR) domain for signal transduction (Botos et al., 2011). Upon ligands 
binding, the extracellular domain dimers form ‘m’ shape which brings the C-terminal of 
leucine-rich repeats and intracellular domains in close proximity (Botos et al., 2011). TLRs 
and downstream signalling cascades are bridged by adaptor proteins, including myeloid 
differentiation primary response 88 (MyD88), TIR domain-containing adapter-inducing 
IFN-β (TRIF), MyD88 adaptor-like (Mal) (Valkov et al., 2011), TRIF-related adaptor 
molecule (TRAM), and Sterile-α and HEAT-Armadillo motif-containing protein (Carlsson 
et al., 2016). All TLRs except TLR3 share MyD88-mediated signalling, whereas TLR3 and 




Table 1.3 Human TLRs and their exogenous ligands. 
TLR Localisation PAMPs Origin of the 
ligands 
Reference 
TLR1 Cell surface Triacyl lipopeptides Gram-negative 
bacteria, 
Mycoplasma 
Shimizu et al., 
2007 





Into et al., 
2004; Jouault 
et al., 2003; 
Schwandner et 
al., 1999; Love 
et al., 2010; 
Muller-Anstett 
et al., 2010  
TLR3 Endolysosome dsRNA, Poly I:C Viruses Alexopoulou et 
al., 2001 
TLR4 Cell surface LPS Gram-negative 
bacteria 
Chow et al., 
1999 
TLR5 Cell surface Flagellin Bacteria Hayashi et al., 
2001 
TLR6 Cell surface Diacyl lipoprotein Gram-positive 
bacteria 
Into et al., 2004 
TLR7 Endolysosome ssRNA, guanosine Viruses Diebold et al., 
2004; Zhang et 
al., 2016 




TLR9 Endolysosome Unmethylated CpG-DNA, 
chromatin-IgG complexes 
Bacteria, viruses Leadbetter et 
al., 2002; Rutz 
et al., 2004 
TLR10 Endolysosome dsRNA Viruses Lee et al., 2018 
 
1.2.2.3 TLR-mediated signalling pathways 
The adaptor protein for most TLRs, MyD88 plays a central role in TLR-mediated signalling. 
MyD88 deficiency increases bacterial burden and dampers host defence to S. aureus 
infection (Dudek et al., 2016; Takeuchi et al., 2000; Weiss et al., 2005). Activated TLRs 
recruit MyD88 by interaction between their TIR domains. As shown in Figure 1.4, MyD88 
recruits and activates IL-1 receptor-associated kinase (IRAK) 4, via death domain-death 
domain association. IRAK4 activates IRAK1/2, leading to autophosphorylation of the 
IRAKs complex and subsequently the activation of TNF receptor associated factor (TRAF) 
6 (Lin et al., 2010). TRAF6 forms a ubiquitin chain with E2 enzyme Ubc13-Uev1A, which 
promotes polyubiquitination of TRAF6 and inhibitor of nuclear factor κ-B kinase (IKK) γ 
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(Chen, 2005). Ubiquitinated TRAF6 activates TGF-β-activated kinase (TAK) and TAK1-
binding (TAB), whereby the TAK1/TAB complex leads to the activation of the three-tier 
MAPK module, MAP3K, MAP2K and finally MAPK including stress-related kinase (Erk) 
1/2,  p38, and c-Jun N-terminal kinase (JNK) (Schröder et al., 2001; Wang et al., 2001; 
Dhanasekaran et al., 2007). Members of MAPK family control cell proliferation, survival, 
and differentiation (Li et al., 2003; D'Souza et al., 2008; Khiem et al., 2008). Activation of 
MAPK facilitates phosphorylation and activation of transcription factor activator protein 
(AP)-1 (Akira et al., 2006). Activated IKK complex contributes to phosphorylation and 
degradation of IκBα, depriving its sequestration of p65 NF-κB, and thereby p65 NF-κB 
translocates into the nucleus and regulates transcription of pro-inflammatory cytokines 
(Kawai and Akira, 2007). Notably, MAPK and NF-κB exhibit differential activation 
thresholds in response to TLR4 ligand (Gottschalk et al., 2016). Activation of NF-κB 
occurs at a much lower dose of lipid A (component of LPS) compared to MAPK. Although 
activated NF-κB leads to gene expression and macrophage priming, TNF production is 
only activated in a MAPK-dependent manner. Hence, while NF-κB is responsible for 
sensing sub-threshold antigens, MAPK tightly controls the sensitivity threshold and 
production of pro-inflammatory cytokines. In addition to activating MAPK and NF-κB 
signalling pathways, intracellular TLRs (TLR7, TLR8, and TLR9) regulate type I IFNs 
production via TRAF6. Upon sensing exogenous nucleic acids sequestered in the 
endolysosome, recruited MyD88 activates IRAK complex together with TRAF6, followed 
by activation of IRF7 (Uematsu and Akira, 2007). IRF7 subsequently translocates into the 
nucleus to mediate type I IFNs expression (Cervantes et al., 2011). The detailed 
TLR7/8/9-mediated signalling is described by Kawasaki and Kawai (2014).  
TLR3 and TLR4 are associated with MyD88-independent pathway and lead to production 
of type I IFNs and IL-10 (Häcker et al., 2006). Activation of TLR4 via MyD88-dependent 
signalling results in an early-phase activation of NF-κB. Following TLR4/MD-2/CD14 
endocytosis, TRIF and TRAM are recruited to the complex on endolysosome membrane 
(Fitzgerald et al., 2003; Tanimura et al., 2008). TRAF6 and receptor-interacting protein 
kinase-1 are recruited to TRIF, resulting in the late-phase activation of NF-κB (Kagan et 
al., 2008; Weinlich and Green, 2014). Both phases of NF-κB activation are required for 
pro-inflammatory cytokine production (Kawai and Akira, 2010). TRIF also interacts with 
non-canonical IKKs TRIF and two protein kinases-binding kinase-1 and IKKε, through 
TRAF3, which leads to activation of IRF3 and IRF7, as well as production of type I IFNs 




Figure 1.4 MyD88-dependent and MyD88-independent TLR signalling pathways. 
The MyD88-dependent TLR signalling pathways mainly result in production of inflammatory 
cytokines and chemokines, whereas MyD88-independent signalling pathways are responsible for 
type I IFNs production to promote anti-viral responses. Unlike other TLRs, TLR4 requires both 
pathways at distinct cellular localization and leads to biphasic activation of NF-κB to induce 
production of inflammatory cytokines (own original artwork).    
1.2.2.4 Function of TLRs 
As described above, the main roles of TLRs are sensing infectious stimuli, recognition of 
self and non-self antigens, and induce the production of cytokines and chemokines. In 
addition, the outcome of TLR signalling includes modulation of adaptive immunity, and 
production of antimicrobial peptides. 
The activation of TLRs on DCs leads to DC maturation, antigen presentation to antigen-
specific T cells, and thereby induces activation and differentiation of T cells (Manicassamy 
and Pulendran, 2009; Schweighoffer et al., 2017). Hence, the activation of naïve T cells 
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features increases in major histocompatibility complex, production of costimulatory 
molecules and pro-inflammatory cytokines. Both MyD88 and TRIF are involved in DC 
maturation (Bechelli et al., 2016; Hu et al., 2015). The production of type I IFN contributes 
to cross-priming by DCs (Le Bon et al., 2003). Moreover, TLRs can directly regulate 
proliferation and cytokine production by T/B cells (Reynolds et al., 2010; Schweighoffer et 
al., 2017).  
TLR-mediated signal transduction leads to production of cytokines (such as IL-1, IL-6, IL-
10, IL-13, TNFα, and TGFβ), chemokines (such as IL-8, monocyte chemoattractant 
protein1, macrophage inflammatory protein 2-α, and chemokine ligand 5), and type I IFNs 
(mainly IFNα and IFNβ) (McClure and Massari, 2014). These secreted products play an 
important role in shaping the innate and adaptive immune responses, inflammation, 
survival, and proliferation (Li et al., 2010). Some products serve as pro-inflammatory 
regulators (such as IL-1, IL-8, and TNFα), whereas IL-10 and TGFβ suppress the immune 
response. In addition to inducing antiviral enzymes, type I IFNs modulate DCs, B cells, 
and T cells function in a direct or indirect manner (Trinchieri, 2010). However, in response 
to bacterial infection, type I IFNs promote anti-inflammatory responses through 
suppressing IL-1 production and macrophages (Mayer-Barber et al., 2011).  
Induction of antimicrobial peptides by TLR signalling was first reported in drosophila 
(Tauszig et al., 2000). hBD1-4 (Ryu et al., 2013), inducible nitric oxide synthase (He et al., 
2006; Lewis et al., 2011), LL-37 (Rivas-Santiago et al., 2008), and SPLI (Vroling et al., 
2011) are inducible in response to TLR agonists.  
1.2.2.5 Negative regulation of TLR signalling 
Activation of TLR signalling is a key event in innate immunity. However, uncontrolled TLR-
mediated pro-inflammatory responses may cause immunopathology and autoimmune 
disease. For example, expression of TLRs and their responsiveness are increased in 
macrophages and peripheral blood monocytes from individuals with rheumatoid arthritis, 
systemic lupus erythematosus, or type 1 and 2 diabetes (Huang and Pope, 2009; Dasu 
et al., 2010; Devaraj et al., 2008; O'Gorman et al., 2015). Hence, it is necessary to have 
negative regulation of TLR-mediated responses, at multiple stages including soluble 
decoy TLR, binding sites overlapping, suppression of signal transduction, and inhibition 
of transcription (Figure 1.5). The multi-layered negative regulation indicates two possible 
explanations: first, each negative regulator is indispensable but insufficient to finely tune 
TLR signalling; second, negative regulators function in different tissue, or at different times 
(Liew et al., 2005).   
 41 
Competition of binding sites happens both extracellularly and intracellularly. Extracellular 
soluble TLR2 and TLR4 have been found in human body fluids and the release is 
upregulated in response to PAMPs (Iwami et al., 2000; LeBouder et al., 2003; Oever et 
al., 2014). The expression of soluble TLR requires metalloproteinase that causes the 
shedding of ectodomain of TLR2 (Langjahr et al., 2014). By competitively binding to TLR2 
ligand peptidoglycan as a decoy receptor, soluble TLR2 dampers activation of NF-κB and 
production of pro-inflammatory cytokines (Iwaki et al., 2002). Furthermore, soluble TLR2 
is a biomarker to discriminate inflammatory diseases caused by infectious and non-
infectious agents (Oever et al., 2014). The immunomodulatory effect of soluble TLR2 is 
detailed by Henrick et al. (2016).  
Furthermore, TLR signalling can be blocked intracellularly by molecules containing the 
TIR domain, such as B-cell adaptor for PI3K (BCAP), single immunoglobulin IL-1R-related 
molecule (SIGIRR), and ST2. By TIR-TIR interaction, BCAP binds to TLR adaptor proteins; 
phosphorylated BCAP recruits PI3K to cytoplasmic membrane and initiates PI3K/Akt 
activation, thereby bridging TLR to PI3K/Akt signalling (Ni et al., 2012). There might be 3 
mechanisms involved in anti-inflammatory regulation of BCAP/PI3K. First, activated Akt 
phosphorylation of  glycogen synthase kinase (GSK)-3β contributes to production of the 
anti-inflammatory cytokine IL-10 (Zhang et al., 2016). Furthermore, the transcription factor 
forkhead box protein O (Foxo) 1 is known to enhance production of pro-inflammatory 
cytokines in macrophages and airway epithelial cells (Fan et al., 2010a; Seiler et al., 2013). 
Activation of PI3K/Akt leads to phosphorylation and nucleus exclusion of Foxo1 (Brunet 
et al., 1999). Lastly, a protein-protein interaction study showed that the association 
between BCAP and MyD88 can interfere with TIR-domain signalosome and MyD88-
IRAKs interaction (Guven-Maiorov et al., 2015). Additionally, PI3K/Akt promotes the pro-
inflammatory response by phosphorylating IKK (Bai et al., 2009; Lin et al., 2011); or by 
phosphorylating GSK-3β, the inhibitor of NF-κB (Cremer et al., 2011). The other two TLR 
negative regulators SIGIRR and ST2 are transmembrane receptors containing a TIR 
domain, and hence interfere with TLR- and IL-1R-mediated inflammatory responses, with 
the exception of ST2 which only disrupts MyD88-dependent signalling (Wald et al., 2003; 
Brint et al., 2004; Nold-Petry et al., 2015).  
Inhibition of signal transduction occurs at multiple stages. IRAK-M is a catalytically inactive 
kinase expressed in macrophages and monocytes that interferes with TLR signalling at 
different steps (Kobayashi et al., 2002). Upon stimulation with TLR ligands, IRAK-M blocks 
dissociation of IRAK1/4 from MyD88, and consequently the formation of IRAKs and 
TRAF6 (Kobayashi et al., 2002). Nakayama et al. (2004) reported that induction of 
tolerance by pretreatment with peptidoglycan in macrophages is associated with IRAK-M. 
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IRAK-M decreases IRAK1 kinase activity, as well as blocking recruitment of IRAK1 to 
MyD88.  
Ubiquitinases and deubiquitinases are associated with post-translational modification in 
TLR signalling. SOCS1 and SOCS3 have ubiquitin ligase activity (Hovsepian et al., 2013; 
Yu et al., 2015). Hence, by polyubiquitination, SOCS1 and SOCS3 lead to proteasomal 
degradation of their targets, including Mal (Mansell et al., 2006), TRAF3/6 (Rothlin et al., 
2007; Zhou et al., 2015), and p65 NF-κB (Strebovsky et al., 2011). The anti-inflammatory 
role by SOCSs is reviewed by Inagaki-Ohara (2014). Another ubiquitin ligase Triad3A 
causes proteolytic degradation of TLR4 and TLR9 (Chuang and Ulevitch, 2004),  as well 
as TLR adaptors TRIF and Mal (Bibeau-Poirier and Servant, 2008). Overall, ubiquitinases 
downregulate the level of signal proteins, and thus disrupt or abolish TLR signal 
transduction. Ubiquitination of TRAF6 is an important step to activate TRAF6 for recruiting 
and activating TABs/TAK1 complex. Polyubiquitinated TRAF6 can be a substrate for 
deubiquitinases, such as A20, cylindromatosis D (CYLD), and deubiquitinating enzyme A 
(DUBA, deubiquitinates TRAF3) (Kayagaki et al., 2007;  Bibeau-Poirier and Servant, 2008; 
Sun, 2010). For example, by removing the ubiquitin chain from TRAF6 and disassociating 
TRAF6 and Ubc13/UbcH5c, A20 inhibits LPS-induced NF-κB pathway (Shembade et al., 
2010).  
Detailed TLR endogenous inhibitors are summarised in Liew et al., (2005) and Kondo et 
al., (2012a). Taken together, negative regulators of TLR signalling contribute to immune 
homeostasis, protecting the host from overreactive inflammation and yet ensuring 
sufficient host defence. Individual negative regulators have unique and non-redundant 
roles as deletion of any individual regulators results in hyperresponsiveness. Although 
there is overlapping of target proteins, regulators possibly work in a synergistic manner to 
induce sufficient inhibition. In addition to MyD88-dependent TLR signalling, regulators 
such as Triad3A and DUBA act via a MyD88-independent pathway. Notably, as TRAFs 
are adaptor proteins in TNFR family, inhibition of TRAF3 or TRAF6 suppresses TNFR 
signalling simultaneously (Kondo et al., 2012b). Hence, the pan-inhibition activity of 
negative regulators connects multiple pro-inflammatory pathways and have a stronger 
inhibitory effect. Artificial inhibitors of TLR signalling have great potential to treat chronic 
inflammation and autoimmune diseases; however, so far no TLR antagonists have been 
approved for clinical treatment (Gao et al., 2017). Furthermore, pathogens have evolved 
to disturb TLR signalling by producing multiple enzymes, such as kinase, protease, 
ubiquitinases, and deubiquitinases (McGuire and Arthur, 2015). Thus, it is favourable for 




Figure 1.5 Negative regulators of MyD88-dependent TLR signalling pathways.  
Negative regulators (in red boxes) play nonredundant roles at distinct steps of TLR signalling. 
Generated from shedding of TLR ectodomains, sTLRs competitively bind to PAMPs as 
extracellular decoy receptors. Molecules with TIR domain (BCAP, SIGIRR, and ST2) interferes 
with TLR/MyD88/Mal complex through competing the binding sites. BCAP also activates PI3K 
which leads to production of IL-10 and inactivation of transcription factor Foxo1. IRAK-M dampens 
disassociation of IRAKs and MyD88. Ubiquitinases (SOCS1/3 and Triad3A) and deubiquitinases 
(A20 and CYLD) disrupt posttranslational modification and thus block signal transduction (own 












































 Hypothesis and aims 
The introduction above has described host defences and the multiple mechanisms that 
pathogens have evolved to circumvent these responses.   
Bacterial infections in the LRTI mainly exist in polymicrobial communities. Microbial 
interactions within airway microbiome may alter disease course and clinical outcomes. 
While Bcc colonisation negatively affects the survival of CF individuals, S. aureus infection 
has the opposite effect and may delay lung disease progression. The underlying 
mechanism remains largely unknown. It was hypothesised that S. aureus interacts with 
the host defence by manipulating innate signalling pathways, thereby alleviating 
pathogenesis caused by Bcc virulence. To test this hypothesis, human airway epithelial 
cells were challenged with S. aureus and Bcc single-species infection or co-infection. 
Immune responses by epithelial cells were recorded and compared.  
   
 
Aims: 
• To assess the modulation of single-species S. aureus and Bcc on host signalling 
cascade and inflammatory responses 
• To study the effect of S. aureus / B. cenocepacia co-infection on host signalling 
and inflammatory responses 
• To interpret the host target of Staphylococcal immunomodulatory factors 




























2.1  Human Airway Epithelial Cell Lines 
Human bronchial epithelial 16HBE14o (16HBE, obtained from Prof Dieter C. Gruenert, 
University of California San Francisco, US) was isolated from surface epithelium of 2nd 
division bronchi of a 1-year old male heart-lung transplant patient and transformed by 
simian vacuolating virus 40 large T-antigen (Cozens et al., 1994). 16HBE cells retain tight 
junction, cilia structure, and cystic fibrosis transmembrane conductance regulator 
expression (Cozens et al., 1994). Human airway epithelial Calu-3 was purchased from 
ATCC (HTB-55). Isolated from the pleural effusion of a 25-year old male with a pulmonary 
adenocarcinoma, Calu-3 cells display epithelial morphology, barrier integrity and cystic 
fibrosis transmembrane conductance regulator under defined conditions (Fogh et al., 
1977; Kreft et al., 2015).  
16HBE cells and Calu-3 cells were maintained in complete medium containing Dulbecco's 
Modified Eagle Medium (DMEM), supplemented with 10% (v/v) heat inactivated fetal 
bovine serum (FBS), 100 units/mL penicillin and 100 µg/mL streptomycin (Gibco). Cells 
were incubated in 75 cm2 flasks (Nunc) at 37ºC in a humidified atmosphere with 5% CO2.  
For dissociation, cells were rinsed with 5 mL Dulbecco's phosphate buffered saline 
(DPBS), followed by incubating with 5 mL 0.25% trypsin-EDTA (Gibco) for 10 minutes at 
37ºC. After adding 5 mL complete medium to neutralise trypsin, the number of viable cells 
were determined using trypan blue exclusion. Briefly, 50 µL cell suspension was mixed 
with same volume trypan blue (0.4%), and loaded on a haemocytometer. Viable cells in 
the four large squares were counted and cell density (cells/mL) was calculated as: number 
of viable cells ´ 2 ´ 104 / 4. After centrifugation at 1000 g for 5 minutes, cells were 
resuspended in complete medium and plated out at a density of 5×105 cells/well into 12-
well plates or 2.5×105 cells/well into 24-well plates.  
For storage, cell suspensions were adjusted to 4×106 cells/mL in freeze medium (50% 
DMEM, 40% FBS,10% DMSO, v/v), transferred into cryovials and stored in liquid nitrogen. 
2.2  Bacteria Strains  
The bacterial strains used in this study are listed in Table 2.1. Bacterial cultures were 
inoculated on Luria-Bertani agar (LB, 1% tryptone, 0.5% yeast extract, 1% NaCl, 1.5% 
agar-agar, w/v) from -80ºC stocks every week, incubated at 37ºC for 1 day and kept at 
4ºC. Due to its slow growing nature, Burkholderia strains were incubated at 37ºC for 2 
days and maintained at room temperature. A single colony of the strain was transferred 
to LB broth at 37ºC with shaking for about 16 hours. Overnight cultures were diluted at 1 
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in 20 and cultured until exponential phase as determined by the growth curve. Bacteria 
were centrifuged at 5000 g for 10 minutes and washed once with sterile PBS (0.01 M 
phosphate buffer, 0.0027 M KCl and 0.137 M NaCl). The bacterial cell density was 
adjusted based on optical density (OD) measured at a wavelength of 600 nm to meet 
different multiplicity of infection (MOI, the ratio of bacteria to cells) values. When tryptone 
soya broth (TSB) was used, bacteria were cultured in TSB (1.7% pancreatic digest of 
casein, 0.3% enzymatic digest of soya bean, 0.5% NaCl, 0.25% K2HPO4, 0.25% glucose) 
at 37ºC with shaking for 16 hours.  
Heat-killed bacteria were prepared by adjusting the OD600 of cultures to the desired MOI 
and heating these on a heating block at 100ºC for 1 hour. Bacterial supernatants were 
prepared by centrifuging overnight cultures at 5000 g for 10 minutes and filtered through 
a 0.2 µm membrane. Heat-inactivated supernatants were prepared by heating samples 
at 95 ºC for 10 minutes. To fractionate excreted products from S. aureus, supernatants 
were submitted to 10-kDa- and 3-kDa-cutoff centrifugal concentrators (Vivaspin 20, 
Sartorius), centrifuged at 5000 g for 17 minutes and 180 minutes respectively following 
the manufacturer’s instructions. Supernatants were separated into three fractions: >10000 
molecular weight cut-off (MWCO), 3000-10000 MWCO, and <3000 MWCO. Filtrates and 
concentrates were adjusted to the original volume with LB, followed by filter sterilisation. 
Immobilised proteinase K (PK) was reconstituted in Tris-Cl (50 mM, pH 8) / CaCl2 (10 mM) 
and used at a concentration of 100 μg/mL at 37ºC for 1 hour. To prepare inactivated PK, 
PK was heated at 99ºC for 1 hour. Immobilised PK mixture was subsequently removed 
by centrifugation at 250 g for 10 minutes. All bacterial products were aliquoted and stored 
at -80ºC.  
For long-term storage of bacterial strains, overnight cultures were transferred to a cryovial 
with sterile glycerol (final glycerol concentration 25%, v/v) to limit cellular damage, 
vortexed and stored at -80ºC. 
Table 2.1 Bacterial strains used in this study. 
Strain Characteristics Source Reference 
S. aureus 
MRSA252 Hospital-acquired MRSA, 
fatal post-op septicemia 
E.J.Feil Holden et al., 2004 
MSSA NCTC 6571 Methicillin-sensitive S. 
aureus 
NCTC  
MR31 Clinical isolate R.C. Massey Trzciński et al., 1997 
 48 
MR81 Clinical isolate R.C. Massey Trzciński et al., 1997 
MRSA USA400 Community-associated S. 
aureus 
R.C. Massey Voyich et al., 2006 
MRSA41  R.C. Massey Collins et al., 2010 
MSSA C316  R.C. Massey Robinson et al., 2005 
MSSA NCTC 10788  NCTC  
MSSA Newman Isolated from a secondary 
osteomyelitis infection of a 
TB patient 
R.C. Massey Baba et al., 2008 
MSSA RN4220 Derivative of NCTC8325-4, 
with agrA mutation 
R.C. Massey Nair et al., 2011 
MSSA SH1000 Laboratory strain, derivative 
of NCTC8325 by 
complementation of rsbU 
R.C. Massey O’Neill, 2010 
MSSA160  R.C. Massey Feil et al., 2003 
MSSA209  R.C. Massey Collins et al., 2010 
US119  R.C. Massey  
Bcc 
B. multivorans DSMZ 
13243 
Isolated from a CF patient DSMZ  
B. cenocepacia 
J2315 
Isolated from a CF patient, 
epidemic ET12 lineage 
J. R. W. 
Govan 
Holden et al., 2009 
B. anthina J2552 Botanical isolate J. R. W. 
Govan 
Palfreyman et al., 
1997 
Reference strains    











Table 2.1 (continued) 
 49 
2.3 Biofilm Assay 
Biofilm formation was assessed as described before (Coffey and Anderson, 2014). Briefly, 
overnight cultures were diluted 1:100 with LB, and 100 µL aliquots were added to a 96-
well microtiter plate. After 24 hours incubation at 37ºC on a 3-dimensional rotator, 
planktonic bacteria were removed, and the biofilms were gently rinsed with PBS twice. 
Biofilms were stained with 125 µL of 0.1% (w/v) crystal violet for 10 minutes. Excess 
crystal violet was removed by washing the plate three times in trays filled with lukewarm 
tapwater, after which the biofilm was dried in a 60ºC oven. Crystal violet was dissolved 
with 150 µL of 20% (v/v) acetic acid and 125 µL of each sample was transferred to a new 
plate. The absorption was read at a wavelength of 550 nm.  
2.4 Measurement of Epithelial Barrier Integrity 
2.4.1 Measurement of Transepithelial Electric Resistance (TEER) 
Calu-3 cells were plated into Transwell permeable supports (12 mm diameter, Corning) 
at 5´105 cells/mL, 0.3 mL per insert. The basolateral chamber was supplied with 1 mL 
complete medium. Medium in the apical chamber was removed 48 hours after seeding to 
induce the formation of polarised monolayer with tight junction.  
TEER was monitored by EVOM Volt/Ohm Meter and STX2 electrode (World Precision 
Instrument). STX2 electrode was sterilised in 100% ethanol and washed once with DMEM. 
As shown in the schematic (Figure 2.1), serum-free DMEM (300 µL) was added to the 
apical chamber. After 30 minutes incubation, the long electrode was placed into the 
basolateral chamber and the short electrode in the apical chamber without damaging the 
monolayer. After subtracting the readout of inserts with medium (background) from raw 
data, they were normalised for area, giving TEER values in Ohm.cm2 as in the following 
equation: (total resistance-background resistance) ´ 1.12cm2. Higher value of resistance 
indicates higher confluency of cells on the inserts as less ions can transport through the 
membrane. Calu-3 cells achieved a polarised state within 7 days when the TEER 
reached >400 ohm.cm2. 
Polarised Calu-3 cells were infected apically with MRSA252 and B. multivorans 13243 
(0.5 mL) for 24 hours. TEER was recorded at time 0, 3 and 24 hours post infection. 
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Figure 2.1 Schematic of measuring TEER for airway epithelial cell monolayer. 
STX2 electrode is used to measure the TEER. The total readout includes the electrical resistance 
of the cell monolayer, the membrane and culture medium.  
2.4.2 Flux of Fluorescein Isothiocyanate (FITC) Labelled-Dextran 
Calu-3 cells were infected with MRSA252 and B. multivorans 13243 as described above. 
At 24 hours postinfection, the inserts were washed twice with Hanks’ Balanced Salt 
Solution (HBSS) gently to remove phenol red. Two-hundred-microlitre FITC-dextran 
(molecular weight 3000-5000, 500 µg/mL in HBSS) were applied to the apical side and 
600 µL HBSS to the basolateral side. After 30 minutes incubation at 37 ºC, medium from 
the basolateral chamber was collected and fluorescence intensity was determined using 
a FLUOstar OPTIMA plate reader (BMG Labtech) at 485 nm excitation wavelength and 
530 nm emission wavelength. The readout was normalised by subtracting the background 
(HBSS), and was divided by maximum (the insert without monolayer) to obtain the value 
of percent epithelial permeability. 
2.5 Invasion Assay 
To study the role of PI3K/Akt signalling, epithelial cells were pretreated with LY294002 or 
wortmannin for 30 or 60 minutes until the end of invasion period. 16HBE cells were 
infected with MRSA252, MSSA NCTC 6571, B. multivorans 13243, B. cenocepacia J2315, 
B. anthina J2552, E. coli HB101 or S. Typhimurium NTB6 at MOI 50 for 2 hours. The 
number of bacteria in the inocula were determined by viable count. 16HBE cells were 
rinsed three times with sterile DPBS to remove unattached pathogens and lysed with 100 
µL saponin (1% w/v in trypsin-EDTA). The lysates were plated on LB agar plates to count 
the number of bacteria that were attached to the epithelial cell membrane. Alternatively, 
following 2 hours infection and DPBS rinse, medium was supplemented with antibiotics 
(Table 2.2) to eliminate extracellular bacteria for the time indicated in Table 2.2. To ensure 
more than 99.9% bacterial killing effect, the last DPBS wash was plated on LB agar plates 
as well. Subsequently, epithelial cells were lysed with 100 µL saponin and internalised 
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bacteria were determined by viable count. Adherence is shown as a percentage of the 
inoculum, and internalisation as a percentage of adherence. 
Table 2.2 Antibiotics treatment for bacterial strains. 
Strains Antibiotics Time 
S. aureus isolates Lysostaphin (20 µg/mL) + vancomycin (25 µg/mL) 1 h 
B. multivorans 13243 
B. anthina J2552 
Ceftazidime (1 mg/mL) + amikacin (1 mg/mL) 2 h 
B. cenocepacia J2315 Ciproflaxin (1 mg/mL) + amikacin (1 mg/mL) 2 h 
E. coli HB101 Gentamicin (200 µg/mL) 1 h 
S. Typhimurium NTB6 Gentamicin (200 µg/mL) + ampicillin (50 µg/mL) 1 h 
 
2.6 Western Blot Analysis 
After stimulation, 16HBE or Calu-3 cells were rinsed with cold DPBS twice and lysed with 
100 µL RIPA buffer (1% Triton X-100, 1% sodium deoxycholate, 25 mM Tris-Cl pH 8.0, 
150 mM NaCl), supplemented with PhosSTOP (Roche) and protease inhibitor cocktail (2 
mM AEBSF, 0.3 μM aprotinin, 116 μM bestatin, 14 μM E-64, 1 μM leupeptin 1 mM EDTA; 
Sigma) just before use. Lysates were collected, centrifuged at 13 000 g for 10 minutes at 
0ºC and the protein concentrations were quantified using Pierce™ BCA Protein Assay Kit 
(Thermo Scientific) according to the manufacturer’s instructions. Briefly, 10 μL of sample 
was diluted 1 in 10 with Milli-Q water, and 25 μL of diluted sample was pipetted into a 96-
well microtiter plate in triplicate and mixed with 200 μL Working Reagent (0.08% cupric 
sulfate w/v). Standards ranged from 25 to 2000 μg/mL. The plate was covered and 
incubated at 37ºC for 30 minutes. The absorbance was read at a wavelength of 550 nm.  
Protein samples with equivalent total protein concentrations were mixed with 5 ´ loading 
buffer (250 mM Tris-Cl pH 6.8, 500 mM dithiothreitol, 10% SDS, 0.25% bromophenol blue, 
50% glycerol, 2% β-mercaptoethanol added before use, v/v). After 95ºC heat-treated for 
5 minutes, aliquots were resolved on a 10% SDS-PAGE gel at 90 volts for 30 minutes and 
then increased to 110 volts for about 1 hour (Mini-Protein Tetra Cell System, Bio-Rad). 
Proteins were transferred to a nitrocellulose membrane at 150 mA for 1.5 hours (Mini 
Trans-Blot Cell, Bio-Rad). Running buffer is composed of 190 mM glycine, 25 mM Tris 
base, 0.1% w/v SDS, and transfer buffer is composed of all these chemicals 
supplemented with 20% v/v methanol. 
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To minimise nonspecific binding of the primary antibodies, the membrane was blocked 
with 5% (w/v) skimmed-milk in TBS (50 mM Tris-Cl, 150 mM NaCl, pH 7.5) for 1 hour at 
room temperature. Membranes were probed with primary antibodies anti phospho-Akt, 
phospho-GSK-3β, phospho-NF-κB-p65, phospho-p38, phospho-Erk, phospho-IκBα, or 
IκBα (Cell Signaling Technology), respectively at 4ºC with gentle rotation overnight. For 
anti phospho-IκBα and IκBα, same amount of proteins was loaded twice on separate gels 
and probed separately. After washing with 3´TBST (TBS-0.1% v/v Tween-20) and TBS 
(each wash 5 minutes), the membranes were then probed with the secondary antibodies, 
IRDye 800 donkey anti-mouse IgG or 680 donkey anti-rabbit IgG (1:10000 in 5% BSA-
TBST) for 1 hour. The blots were washed with 3 ´ TBST and TBS. Quantitative analysis 
of the signals from each antibody was performed using the Li-Cor Odyssey Clx imaging 
system. The membranes were subsequently probed with primary antibodies anti Akt, p38, 
or Erk, respectively (Cell Signaling Technology), and secondary antibodies as previous. 
Signal intensity was normalised as a percentage of total Akt, p38 or IκBα on the same 
membrane.  
2.7 Detection of Cytokine Production 
At the end of stimulation, conditioned medium of 16HBE cells was centrifuged at 5000 g 
for 10 minutes and supernatants were analysed for IL-8 using a commercially available 
ELISA kit (eBioscience) according to the manufacturer’s instructions. Briefly, Maxisorp 
ELISA plates (Nunc) were coated with 100 µL capture antibody at 4ºC overnight. The 
wells were washed three times with Wash Buffer (0.05% v/v Tween-20, PBS) and blocked 
with 200 µL diluent for 1 hour at room temperature. For each assay, human IL-8 standard 
was reconstituted using 1 mL distilled water and diluted with ELISA Diluent to 250 pg/mL. 
The standard curve included 8 points by performing serial 2-fold dilutions of the top 
standard (range, 2-250 pg/mL). One-hundred microliter standards, samples, and ELISA 
Diluent (blank) were added to the plate in duplicate. After 2 hours incubation, the wells 
were washed as previous. The wells were incubated with 100 µL detection antibody for 1 
hour, followed by 3 washes. After 30 minutes incubation with 100 µL Avidin-HRP, the 
wells were rinsed 5 times. One-hundred microliter TMB Solution was added to the wells 
until 15 minutes later the reaction was stopped by adding 50 µL Stop Solution (2N H2SO4). 
The optical density was read at 450 nm and 550 nm, using a FLUOstar OPTIMA (BMG 
Labtech) microplate reader. The values of 550 nm were subtracted from those of 450 nm; 
the values of the blank wells were subtracted from those of standards and samples. 
Standard curve was generated by graphing concentration of IL-8 versus optical density 
and used to determine the concentration of IL-8 in the samples.    
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2.8 Cell Viability Assay 
To confirm that the modulation of IL-8 production by heat-killed S. aureus or the 
supernatants was not due to cell damage, epithelial metabolic activity was assessed using 
the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). 16HBE 
cells were plated in 96-well plates (5000 cells/well) and incubated for 24 hours. At 24 
hours post-stimulation with 10% (v/v) S. aureus supernatants or heat-killed S. aureus, 
cells were cultured with 12 mM MTT-DMEM for 2 hours. Formazan formed from MTT in 
viable cells was dissolved in DMSO for 10 minutes before the optical density was read at 
550 nm wavelength. 
To determine cell damage caused by live bacteria, 16HBE cells were stimulated with S. 
aureus strains (MOI 0.5) and B. cenocepacia J2315 (MOI 5). 16HBE were seeded at 
2´104 cells/well in 96-well plates one day before experiments (0.1 mL DPBS into the 
peripheral wells of the 96-well plates). At 2 hours postinfection, cells were rinsed with 
DPBS twice and then incubated for 24 hours in 0.1 mL phenol red-free DMEM to minimise 
background absorbance. Lactate dehydrogenase (LDH) release was measured with an 
LDH Cytotoxicity Assay Kit according to manufacturer’s instructions (Pierce). Briefly, 45 
minutes before collecting supernatants, 10 µL sterile water was added to one set of 
triplicate wells as spontaneous LDH activity control; 10 µL Lysis Buffer was added to 
another set of triplicate wells as maximum LDH activity control. After incubated at 37ºC 
for 45 minutes, 50 µL supernatants were mixed with 50 µL reaction mixture in a new 96-
well plate and incubated at room temperature for 30 minutes in the dark. The reaction was 
stopped by adding 50 µL Stop Solution. The absorbance was read at 450 nm and 600 nm, 
using a FLUOstar OPTIMA (BMG Labtech) microplate reader. The 600 nm absorbance 
value was subtracted from the 450 nm absorbance value. Background control value 
(DMEM with no cell) was subtracted from average of each sets of readouts and 
calculated %Cytotoxicity using the following equation.   
%Cytotoxicity=100´(samples value-spontaneous LDH activity control)/maximum LDH 
activity control 
2.9 Statistical Analysis 
Data were expressed as the mean ± standard error of the mean (SEM) n³3 independent 
biological repeats. Results were compared using one-way or two-way ANOVA, followed 
by Tukey or Dunnet multiple comparisons test, with p<0.05 considered significant. The 
Pearson correlation score with two-tailed test of significance was used for rank 
correlations.  
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2.10 Reagents and Consumables 
Table 2.3 Reagents and consumables for mammalian cell and bacteria culture. 
Product Supplier Catalog number 
Reagents and consumables for cell culture 
12-well clear sterile plate Thermo, UK 150628 
24-well clear sterile plate Corning, UK 3527 
96-well black plate Greiner Bio-one, UK 655087 
96-well clear sterile plate Corning, UK CLS3595 
DMEM Gibco, UK 41966052 
DPBS Gibco, UK 14190250 
FBS Gibco, UK 10082147 
HBSS Gibco, UK 14025092 
Penicillin-Streptomycin Gibco, UK 15140122 
T75 cell culture flasks Nunc, UK 156499 
Transwell cell culture inserts Sigma, UK CLS3460 
Trypsin-EDTA (0.25%) Gibco, UK 25200072 
Tweezer electrode World Precision Instrument STX2 
Reagents and consumables for bacterial cultures 
Agar-agar Fisher, UK 10548030 
Immobilised proteinase K Sigma, UK 82452 
LB broth, Miller Fisher, UK BP1426 
PBS tablets Sigma, UK P4417 
Tryptone soya broth Oxoid, UK CM0129 
Vivaspin, 10000 MWCO Sartorius, UK VS2001 









Table 2.4 Drugs for in vitro treatment. 
Product Supplier Catalog Number 
Flagellin, FLA-ST Invivogen, UK tlrl-stfla 
hTLR5-Fc Invivogen, UK fc-htlr5 
Lipopolysaccharides Sigma, UK L2880 
LPS-RS Invivogen, UK tlrl-rslps 
LY294002 Sigma, UK L9908 
Pam3CSK4 Invivogen, UK tlrl-pms 
Recombinant human IL-1β Peprotech, UK 200-01B 





Table 2.5 Reagents for western blot. 
Product Supplier Catalog Number 
2-mercaptoethanol Sigma, UK M3148 
30% acrylamide/bis Bio-rad, UK 1610154 
Ammonium persulfate Fisher, UK 10744171 
Glycine Fisher, UK 10080160 
Prestained protein standards Bio-rad, UK 1610375 
Protease inhibitor cocktail Sigma, UK P2714 
Roche PhosSTOP tablets Sigma, UK 4906845001 
SDS Sigma, UK L3771 
TEMED Fisher, UK 10549960 










Table 2.6 List of primary antibodies. 
Antigen target Product Numbera Dilution Diluent Host 
Akt 2920 1:2000 5% skimmed-milk-TBST Mouse 
Erk1/2 4695 1:1000 5% BSA-TBST Rabbit 
IκBα 4814 1:1000 5% skimmed-milk-TBST Mouse 
p38 8690 1:1000 5% BSA-TBST Rabbit 
Phospho-Akt (S473) 4060 1:2000 5% BSA-TBST Rabbit 
Phospho-Akt (T308) 13038 1:1000 5% skimmed-milk-TBST Rabbit 
Phospho-Erk1/2 9106 1:2000 5% skimmed-milk-TBST Mouse 
Phospho-GSK-3β 5558 1:1000 5% BSA-TBST Rabbit 
Phospho-IκBα 9246 1:1000 5% skimmed-milk-TBST Mouse 
Phospho-p38 
(T180/Y182) 
9216 1:2000 5% skimmed-milk-TBST Mouse 
Phospho-p65 3033 1:1000 5% BSA-TBST Rabbit 
a All the products were purchased from Cell Signaling Technology, MA, US 
 
Table 2.7 List of secondary antibodies. 
Product Product Number Supplier 
IRDye 800CW donkey anti-mouse 92632212 Li-Cor, UK 
IRDye 680RD donkey anti-rabbit 92668073 Li-Cor, UK 
 
 
Table 2.8 Assay kits. 
Product Product Number Supplier 
IL-8 human ELISA kit eBioscience, US 88-8086-88 
Pierce BCA protein assay kit Thermo, UK 23225 
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3.1     Introduction 
The lung is the major organ of the respiratory system in humans. It is exposed to inhaled 
microorganisms and particles continuously. To resist infectious attack, the lung has 
developed sophisticated defence mechanisms. The physical barrier which comprises of 
airway epithelial cells and the mucus layer plays a major role in limiting entry and assisting 
clearance of pathogens. The coordinated beating of the cilia on the apical surface of 
epithelial cells enables removal of particles that are trapped by mucus (Bustamante-Marin 
and Ostrowski, 2017). Paracellular junctional complexes play an essential role in 
controlling the transport of water, ions and immune cells, and separating airborne 
pathogens from the interior of the body to maintain homeostasis in the lung (Brune et al., 
2015). However, the epithelial barrier is compromised when the traversal of pathogens 
occurs (Kim et al., 2005; Malik et al., 2015). To study the barrier function, cells can be 
cultured on a porous membrane, which is the most common method to represent the 
morphology and tight junctions of airway epithelial cells in vitro (Grainger et al., 2006). In 
this it is important that the cells used do polarise and form tight junctions as cells would 
normally do in vivo; not many pulmonary cell lines do, but the Calu-3 cell line is one of the 
few exceptions (Shen et al., 1994). When a confluent monolayer is achieved, the apical 
side is separated from the basolateral membrane and therefore displays a certain TEER 
value, which is a measure of the integrity of airway epithelial. This integrity may be 
compromised by bacteria, but so far little work has been done on effect of MRSA and Bcc, 
two major lung infection species.  
Airway epithelial cells also serve as a sentinel to detect intruding pathogens through a 
wide range of PRRs (Takeuchi and Akira, 2010). Activation of PRRs lead to a sequence 
of events, including activation of downstream signalling pathways, initiation of the 
expression of proinflammatory cytokines, and recruitment and activation of immune cells 
to the site of infection. Eventually pathogens are resolved by phagocytosis, or 
antimicrobial substances released by professional phagocytes if the microbial clearance 
is successful (Nagl et al., 2002). In this process, IL-8 plays an important role at the early 
stage of infection by chemoattracting granulocytes such as neutrophils. Hence, the level 
of IL-8 is a biomarker of pro-inflammatory responses and inflammation.  
The PI3K/Akt pathway is one of the downstream signalling cascades activated by TLRs, 
regulating a wide range of cellular functions, such as survival, proliferation and the 
inflammatory response (Hawkins and Stephens, 2015; Rosadini and Kagan, 2017). For 
example, Akt is required for the proinflammatory response to B. cenocepacia in human 
peripheral blood mononuclear cells (PBMC) using a PI3K inhibitor (Cremer et al., 2011). 
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In contrast, inhibition of PI3K/Akt signalling abolished anti-inflammatory cytokine IL-10 
production but did not affect proinflammatory cytokine TNFα production by PBMCs in 
response to S. aureus isolates (Peres et al., 2015). Therefore, the discrepancy of PI3K/Akt 
signalling might indicate that it has pleiotropic roles in regulating inflammatory response, 
depending on the stimulus and other signals generated.       
S. aureus and Bcc are the leading cause of lower respiratory tract infections. Despite 
being a commensal microbe in the respiratory tract, S. aureus is able to colonise the host 
in a pathogenic manner, which leads to pneumonia with an intense and exaggerated host 
response. The major challenge of S. aureus infection is rapidly evolved antibiotic 
resistance (Foster, 2017). After acquisition of the resistance gene SCCmec, a subgroup 
of S. aureus becomes resistant to most β-lactam antibiotics, namely MRSA. The incidence 
of individuals with CF harbouring MRSA increased from 5% to 26% from 2000 to 2010, 
and this has plateaued ever since (Cystic Fibrosis Foundation, 2017). On the other hand, 
the prevalence of Bcc is about 3% among persons with CF. The acquisition of 
Burkholderia infections are most likely from the natural environment such as soil, and 
some epidemic strains are well adapted to infectious disease and have greater ability for 
interpatient transmission (Govan et al., 1993; LiPuma et al., 2002). While some patients 
have no deterioration, about 20% of infected patients develop cepacia syndrome either 
soon after the first positive isolate or many years after (Blackburn et al., 2004). Cepacia 
syndrome is a fatal illness characterised as rapid deterioration of pulmonary function, 
bacteremia and sepsis. Pre-operative Bcc colonisation is also a significant marker for post 
lung transplantation mortality (De Soyza et al., 2010). The difficulty of treating Bcc is 
recognised with their intrinsic and acquired antibiotic resistance. Multi-antibiotic resistance 
is observed in Burkholderia species due to the expression of β-lactamase, efflux pump 
and outer membrane permeability barrier (Fraser-Pitt et al., 2016; Rhodes and Schweizer, 
2016).  
In chronic lung infections, microbial pathogens tend to form so-called biofilms to promote 
long-term survival under the stress coming from antibiotics treatment and the immune 
clearance (Archer et al., 2011). These biofilms are sessile communities of bacteria 
embedded within a self-produced matrix on biotic or abiotic surfaces. Biofilm extracellular 
polymeric substances comprise polysaccharides, proteins, glycoproteins, glycolipids, and 
extracellular DNA. Bacteria in biofilm displays altered phenotypes with respect to gene 
expression, protein production and growth rate (Donlan and Costerton, 2002). By 
adapting to the sessile type of life, microorganisms in biofilm benefit from several 
advantages over their planktonic counterparts. The majority of cells in biofilm communities 
are dormant due to the lack of oxygen and nutrients. Hence, the low metabolic rate and 
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quiescent state downregulate the susceptibility to antimicrobial agents that inhibit 
synthesis in the process of cell division (Høiby et al., 2010). In addition, the diffusion 
barrier in biofilms plays a critical role to reduce the penetration of antimicrobial factors. 
Indeed, antimicrobial agents can be inactivated or absorbed by the matrix layer before 
reaching the inner layer of bacteria. For example, a study proved that the polysaccharide 
Poly-β-1,6-N-acetyl-D-glucosamine in the biofilm matrix restricts fluid transport and 
sequesters the biocide cetylpyridinium chloride within biofilms of Actinobacillus 
pleuropneumoniae and S. epidermidis (Ganeshnarayan et al., 2009). In the final stage of 
the life cycle of a biofilm, bacteria can detach from the community and disseminate to 
uninfected sites. Biofilm dispersal is regulated by environmental factors, such as shear 
stress, and biological signalling. It is a vital step between the persistence and 
dissemination of bacterial pathogens (Guilhen et al., 2017). Overall, biofilm formation 
represents a key virulence factor of microorganisms.  
This chapter was aimed at investigating the host response to bacterial pathogens in 
airway epithelial cell lines. First, the disruptive effect on in vitro epithelial monolayer model 
by S. aureus and B. multivorans were characterised. One of the major virulence factors, 
biofilm formation, was compared between S. aureus and Bcc. Finally, the role of PI3K in 
the production of the neutrophil chemoattractant IL-8 in response to S. aureus and Bcc 
was assessed by the use of PI3K inhibitors.  
3.2    Airway Barrier Function Is Compromised by Bacterial Pathogens 
Bacterial invasion compromises the barrier integrity of the tight junctions and epithelial 
cell death. To assess the integrity of infected Calu-3 monolayers, TEER and FITC-dextran 
flux were monitored.  
TEER levels did not change in the first 3 h infection either with MRSA252 or B. multivorans 
13243, but a pronounced drop was achieved at 24 h. A difference was observed between 
MRSA252 and B. multivorans. At 24 h, a CFU-dependent decrease was monitored in 
MRSA252-treated groups, whereas B. multivorans-treated monolayers showed the same 
level of reduction at all dose levels examined (Figure 3.1A and B).  
To further assess airway epithelial barrier compromise, the diffusion of FITC-dextran (4 
kDa) from the apical to basolateral chamber was measured at 24 h postinfection. FITC-
dextran detected from the basolateral chamber showed a dose-dependent increase 






Figure 3.1 Compromised Calu-3 barrier by MRSA252 or B. multivorans 13243 invasion. 
Polarised Calu-3 monolayers were exposed to increasing CFU of MRSA252 and B. multivorans 
13243 (0.5 mL apically). (A and B) TEER levels were recorded at 3 and 24 h post infection. N=3 
independent experiments, performed in duplicate. Error bars indicate mean ± SEM. Data were 
analysed using two-way ANOVA with Dunnett's multiple comparisons test between untreated and 
infected monolayers. *, p< 0.05. (C and D) Diffusion of FITC-dextran through compromised 
monolayers at 24 h. Data are presented as percent of maximum diffusion (inserts with no cells) 
and analysed by one-way ANOVA with Dunnett's multiple comparisons test. Compared to 























































































3.3 Evaluation of Biofilm Formation by Bcc and S. aureus sp.  
To assess biofilm formation of Bcc and S. aureus isolates, crystal violet staining was used 
(Figure 3.2). Cystic fibrosis-isolated strains B. multivorans 13243 (absorbance readings 
of 1.35 ± 0.26) and B. cenocepacia J2315 (0.60 ± 0.09) formed abundant biofilms 
compared to the environmental isolate B. anthina J2552 (0.10 ± 0.03). S. aureus strains 
formed same levels of biofilm (0.92 ± 0.42) except MSSA SH1000 (2.80 ± 0.23), which 
formed 2 times more biofilm than the average biofilm formation. Notably, SH1000 and 
RN4220 share the same ancestral strain NCTC 8325, but that RN4220 only produced half 
the amount of biofilm as compared to SH1000. Strain RN4220 differs from SH1000 with 
defective agrA and rsbU genes, which are important virulence regulators (Traber and 
Novick, 2006; Bæk et al., 2013). Compared to RN4220, SH1000 has stronger haemolytic 
and proteolytic activity, and produces golden pigmentation (Bæk et al., 2013). Overall, 





Figure 3.2 Biofilm formation by Bcc and S. aureus strains. 
Overnight bacterial cultures were diluted, plated into 96-well polystyrene plates, and incubated at 
37ºC on a 3-dimentional rotator for 24 h. Biofilm structure was quantified by staining with crystal 





































































































3.4 Modification of IL-8 Production by B. cenocepacia and S. aureus sp. 
in 16HBE Cells 
To study the effect of bacterial pathogens on IL-8 production, 16HBE cells were infected 
with B. cenocepacia J2315 (MOI 5) and S. aureus strains (MOI 0.5) for 24 h. IL-8 
concentration in the culture medium was determined using ELISA. Under basal conditions 
16HBE cells produced low level of IL-8, indicating it has endogenous IL-8 expression 
(Figure 3.3A). CF-isolated pathogen B. cenocepacia J2315 induced a greater level of IL-
8 (increased by 102%, p<0.05) compared to the baseline. Interestingly, S. aureus isolates 
possessed different abilities of inducing IL-8 in 16HBE cells. Strains such as Newman, 
NCTC 6571 and MRSA252 induced much less IL-8, whereas some strains stimulated 
abundant levels of IL-8 (SH1000, C316, RN4220, and USA400, p<0.05). However, 
bacterial pathogens cause damage to epithelial cells, which could potentially result in 
reduced IL-8 accumulation. To eliminate this possibility, the LDH assay was used to 
assess cytotoxicity of B. cenocepacia J2315 and S. aureus isolates (Figure 3.3B). Under 
basal conditions, a minimal amount of LDH was released (1.9 ± 1.1 %). Even though the 
inoculum CFU of B. cenocepacia J2315 was 10 times higher than S. aureus, it caused 
the lowest level of cell damage (11 ± 1.6 %). This might due to the slow growing nature of 
J2315 (Kaza et al., 2010), which results in minimal amount of toxins secretion. Among the 
cytotoxic S. aureus isolates, Newman and NCTC 10788 were isolated from a human 
lesion, MRSA41 is hospital-acquired MRSA, while C316 and USA400 are community-
associated S. aureus. Most S. aureus strains that significantly reduced IL-8 production did 
not show major cytotoxicity, indicating that the inhibition of IL-8 production was not due to 
cell death. As biofilm formation is a key virulence factor, we compared IL-8 production in 
response to B. cenocepacia J2315 or S. aureus isolates versus biofilm development in 
vitro (Figure 3.3C). However, no correlation was observed between these two variables 
(r2=0.06689, p=0.3520). Taken together, S. aureus species show heterogeneity in 











Figure 3.3 IL-8 production and cytotoxicity caused by B. cenocepacia J2315 and S. aureus 
sp. in 16HBE cells. 
(A) IL-8 secretion in response to B. cenocepacia J2315 (MOI 5) and S. aureus sp. (MOI 0.5) for 24 
h. Data are presented as mean ± SEM from three independent experiments in duplicate. Statistical 
analysis was performed using two-way ANOVA with Dunnett's multiple comparisons test. (B) 
Cytotoxicity of B. cenocepacia J2315 (MOI 5) and S. aureus sp. (MOI 0.5) by measuring LDH 
release. Data are plotted as mean ± SEM from three independent experiments performed in 
triplicate. Statistical analysis was performed using one-way ANOVA with Dunnett's multiple 
comparisons test. *, p<0.05 compared to the control. (C) Scatter plot of IL-8 production in response 
to B. cenocepacia J2315 or S. aureus isolates versus biofilm formation. Correlation between biofilm 









































































































































































































3.5 PI3K is required for the proinflammatory response to B. cenocepacia 
J2315  
To define the role of PI3K/Akt on host response to S. aureus or Bcc infections, 16HBE 
cells were pretreated with LY294002 or wortmannin for 1 hour and infected with S. aureus 
or Bcc at an MOI of 50. IL-8 concentration in the cultured medium was quantified using 
ELISA. A heterogeneity was seen in Bcc-induced IL-8 production in the absence of PI3K 
inhibitors (Figure 3.4). Despite B. multivorans 13243 and B. cenocepacia J2315 isolated 
from CF individuals, J2315-infected 16HBE cells produced threefold more IL-8 compared 
to 13243-infected. As expected, the chemokine response to botanical isolate B. anthina 
J2552 was the lowest, which was consistent with biofilm formation. A slightly higher 
concentration of IL-8 was seen in response to MRSA252 in comparison with MSSA NCTC 
6571. Little or no reduction was seen with the presence of LY294002 or wortmannin, with 
the exception of J2315. In consistence with Cremer et al (2011), pretreatment with 
LY294002 or wortmannin caused significant reduction in the J2315-induced IL-8 response 
(decreased by 34% and 26%, respectively). Thus, these results indicate that the 
proinflammatory response to J2315 requires PI3K activity in 16HBE cells.  
Due to its strong ability of inducing pro-inflammatory chemokine, B. cenocepacia J2315 
was chosen to investigate pro-inflammatory responses and modulation on host signalling 
for future experiments.  
                      
Figure 3.4 IL-8 response to S. aureus and Bcc with the presence or absence of PI3K 
inhibitors in 16HBE cells. 
Cells were treated with LY294002 (30 μM) or wortmannin (100 nM) for 1 hour before infected with 
S. aureus or Bcc at an MOI of 50. At 2 h postinfection,16HBE cells were rinsed with DPBS twice 
and incubated in fresh DMEM for 18 h. IL-8 production was quantified by ELISA. Data are 
presented as mean ± SEM from three independent experiments performed in duplicate. *, p<0.05 
compared to J2315-infected cells without any PI3K inhibitors; #, p<0.05 compared to the control; 
using two-way ANOVA followed by Dunnett's multiple comparisons test.  

















































In this chapter, we investigated the host response to Bcc and S. aureus isolates, 
respectively, including the disruption of the airway barrier, induction of pro-inflammatory 
chemokine IL-8, and cell damage.    
Primary airway epithelial cells and cell lines are widely used in host-pathogen interaction 
studies. Culturing Calu-3 cells on a permeable membrane has proven to represent a great 
similarity to primary human bronchial epithelial cells phenotype, with cilia-like structures, 
secretory granules and a high TEER (Grainger et al., 2006). Human bronchial epithelial 
cells are considered to be the most physiological model, but they have a highly 
differentiated phenotype due to donor variation, experiment and passage. Calu-3 cells 
have a more reproducible TEER and phenotype, although data have shown some 
distinctive differences, such as ZO-1 (a tight junction marker) expression and β-tubulin IV 
(a ciliated cell marker, expression localised to the cell boundaries) localisation (Stewart et 
al., 2012). The modulation of MRSA252 and B. multivorans 13243 on TEER value and 
FITC-dextran diffusion of Calu-3 monolayers proves the disruptive effect on the integrity 
of airway epithelial monolayers. Studies working on Calu-3 cells show that S. aureus 
isolates and B. multivorans 13243 caused large falls in TEER (Kiedrowski et al., 2016; 
Duff et al., 2006). Furthermore, S. aureus-secreted products are potent at breaching tight 
junctions of epithelial barriers (Malik et al., 2015). Duff et al. (2006) demonstrate that 
although all the tested Bcc isolates reduced TEER within 4 h, translocation speed of Bcc 
from the apical to the basolateral chamber differs. In order to study the translocation in 
our model, we cultured Calu-3 cells on 3 μm pore size polyester membrane to allow 
pathogens to pass through. Despite exhibiting a high TEER value (~600 Ohm.cm2), Calu-
3 cells formed ‘leaky’ monolayers on 3 μm membranes compared with 0.4 μm filter 
cultures. Therefore, filter pore size can affect cell morphology and cell densities. In a 
preliminary experiment, translocation was tested with MRSA252, MSSA NCTC 6571, B. 
multivorans 13243, E. coli HB101 and S. Typhimurium NTB6 at an MOI of 50 for 6 h 
apically. No translocation was observed except the invasive reference strain S. 







Table 3.1 Translocation in airway epithelial monolayer 








Inoculum 0 h 5.8 ´ 106 4.8 ´ 106 5.3 ´ 106 5.4 ´ 106 5.6 ´ 106 
Basolateral 
chamber  
2 h 0 0 0 0 1.5 ´ 104 
4 h 0 0 0 0 3.9 ´ 106 
6 h 0 0 0 0 3.8 ´ 107 
Apical 
chamber 
6 h 3.3 ´ 107 2.9 ´ 107 3.6 ´ 108 6.0 ´ 107 N/A 
 
Biofilm formation is a major challenge of bacterial eradication, particularly in chronic lung 
infections. We showed differential biofilm development with a selection of Bcc and S. 
aureus strains. As expected, CF-associated isolates developed more robust biofilms 
compared to the environmental isolate J2552. B. cenocepacia J2315 belongs to the 
epidemic lineage ET12, which makes up the majority of B. cenocepacia isolates from CF 
patients and accounts for a dramatically shorter survival expectancy (Jones et al., 2004). 
Isolates of B. multivorans and B. cenocepacia have been shown to form stronger biofilm 
and are more invasive of 16HBE cells than B. cepacia, B. stabilis and B. vietnamiensis 
(Caraher et al., 2007). A study (Cunha et al., 2004) described the isolation of 15 Bcc 
strains from 21 CF patients and the testing the abilities of biofilm formation in vitro. 
Although the results suggested that the virulence of lung infections caused by Bcc is not 
correlated with biofilm formation, three patients who died during 7-year surveillance period 
were hosting biofilm-forming strains. Our results show that S. aureus strains have different 
abilities of biofilm development, and it is uncoupled with their abilities of IL-8 induction, 
which suggests the proinflammatory response of airway epithelial cells caused by S. 
aureus depends on virulence determinants other than biofilm formation.  
The recognition of microorganisms is the first step of host defence. The Gram-negative 
pathogen B. cenocepacia J2315 has prototypical agonists for TLR2, 4 and 5, which are 
lipopeptide, LPS and flagellin, respectively (West et al., 2009); whereas Gram-positive S. 
aureus species are mainly detected by TLR2. TLR2/1 and TLR2/6 heterodimers recognise 
a wide range of S. aureus cell wall components, such as teichoic acid, peptidoglycan and 
lipoteichoic acid (Fournier and Philpott, 2005). The stimulation of Toll-like receptors by 
conserved microbial surface ligands initiates sequential events, including the activation of 
the NF-κB pathway, proinflammatory cytokine and chemokine secretion, and activation 
and recruitment of professional immune cells. We showed that B. cenocepacia J2315 
elicited a robust IL-8 production, whereas heterogeneity was seen in S. aureus isolates-
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induced IL-8 production. This is consistent with the finding of differential abilities of nasal 
S. aureus isolates to induce proinflammatory cytokine TNFα production by PBMCs (Peres 
et al., 2015). Mayer et al. (2007) demonstrate that human bronchial epithelial cell line 
BEAS-2B cells had dose-dependent IL-8 production in response to Gram-negative 
pathogens whereas they were hypo-responsive to Gram-positive bacteria such as S. 
aureus. TLR2 and its co-receptor CD36 co-transfection restored IL-8 responses to TLR2 
agonists. Therefore, the expression of TLR2 and CD36 are limiting factors of the pro-
inflammatory response to S. aureus. However, in our system, a few MSSA strains 
(SH1000 and RN4220) are strong inducers of IL-8 production, which suggested they might 
express different surface ligands. 
Inhibition of PI3K activity with pharmacological inhibitors did not change IL-8 production 
in S. aureus- or Bcc-stimulated 16HBE cells, with the exception of B. cenocepacia J2315, 
suggesting only J2315 is capable of inducing a robust proinflammatory response of 
16HBE cells that is PI3K-dependent. One possible explanation is the scale of IL-8 
response induced by J2315 is much higher than the other strains, and therefore the 
supressing effect of PI3K inhibitors is inclined to be larger. The concentrations of 
LY294002 (30 μM) and wortmannin (100 nM) used here are typical concentrations for 
inhibiting PI3K activity (Davies et al., 2000). The PI3K regulation of the proinflammatory 
response to B. cenocepacia in macrophages has been reported previously (Cremer et al., 
2011). B. cenocepacia stimulates NF-κB activity by activating PI3K/Akt signalling, 
followed by inactivating the downstream NF-κB repressor GSK3β. However, PI3K/Akt 
plays different roles in the immune response depending on the cell type and stimulus. In 
neutrophils, PI3K promotes migration, phagocytosis, respiratory burst and survival (Martin 
et al., 2015; Luo and Mondal, 2015), whereas in monocytes (Luyendyk et al., 2008), 
macrophages (Androulidaki et al., 2009) and dendritic cells (Fukao et al., 2002), PI3K 
activity negatively regulates the pro-inflammatory response to maintain homeostasis. 
Indeed, defining the role of PI3K in inflammation as a positive or negative regulator is 
oversimplified, as different PI3K and Akt isoforms finely tune the inflammatory responses 
in distinct ways as complex as the inflammatory response itself. For example, while Akt1 
promotes M2 macrophage polarisation, Akt2 contributes to M1 phenotype polarisation 
(Androulidaki et al., 2009; Arranz et al., 2012; Vergadi et al., 2014). Akt1-/- macrophages 
are hypo-responsive to LPS, exhibit higher levels of iNOS and enhanced bacterial 
clearance (Arranz et al., 2012), whereas Akt2-/- macrophages are hyper-responsive to 
LPS, suppress TLR4 signalling through the anti-inflammatory microRNA miR-146a 
(Vergadi et al., 2014). Furthermore, the p110δ isoform of PI3K promotes neutrophil flux 
and inflammation in macrophages (Konrad et al., 2008). PI3K p110δ plays an opposing 
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role in bone marrow-derived dendritic cells by inducing internalisation of TLR4 and 
degradation of the adaptor molecule TIRAP, which switches from proinflammatory phase 
to anti-inflammatory phase, and thereby, enhances anti-inflammatory cytokines (IL-10 and 
IFN-β) production (Aksoy et al., 2012). Furthermore, PI3K p110δ is found to play a 
dominant role in IL-10 production in response to S. aureus through the PI3K/Akt/mTOR 
pathway (Peres et al., 2015). In this project, we intended to investigate the anti-
inflammatory response to S. aureus and Bcc by measuring IL-10 production. However, 
16HBE cells do not express IL-10 at mRNA or protein level (Massengale et al., 1999), and 
we could not detect any IL-10 production using ELISA (data not shown). 
3.7 Conclusions 
The results presented in this chapter demonstrate the host response of airway epithelial 
cells stimulated by S. aureus and Burkholderia cepacia complex isolates. Barrier function 
of polarised airway epithelial cells was disrupted by MRSA252 and B. multivorans 13243. 
S. aureus isolates had differential abilities of inducing IL-8 production, which did not 
correlate with biofilm development. B. cenocepacia J2315 induced a strong IL-8 
production, in part through PI3K signalling. Therefore, the role of PI3K/Akt in infection 















Chapter 4  Investigating the Role of 
PI3K/Akt, MAPK and NF-κB Signalling 

















Bacterial adherence to the airway lumen is an essential step of infection, followed by 
internalisation depending on the lifestyle of the pathogen (Silva, 2012). Multiple bacterial 
surface structures are involved in adhesion and invasion, such as cell wall-anchored 
proteins (Foster et al., 2014), the cable pili (Essex-Lopresti et al., 2005), and flagella 
(Bucior et al., 2012). These adhesins interact with host receptors and activate host kinase 
pathways in order to trigger actin rearrangement, which enables invasion and uptake of 
bacteria by endocytosis (Colonne et al., 2016). By doing so, intracellular bacteria are 
temporally protected from antimicrobial substances (such as nitric oxide, defensins, and 
lysozymes) in the extracellular milieu, as well as evade recognition and phagocytosis by 
immune cells (Eisele and Anderson, 2011). Pathogens exploit the intracellular niche as a 
reservoir for proliferation, and subsequent dissemination which also requires the 
manipulation of actin rearrangement (Colonne et al., 2016). Hence, subverting the 
interaction between pathogen and cytoskeleton may provide a novel antimicrobial 
treatment.    
The microbial detectors (PRRs) are widely expressed in phagocytes and non-professional 
phagocytes such as epithelial cells and fibroblasts (Takeuchi and Akira, 2010). As a family 
of well characterised PRRs, TLRs are involved in host response to bacteria, viruses, and 
parasites. Activation of TLR leads to sequence of events: activation of downstream 
signalling cascades (including the MAPK and NF-κB pathways) (Takeuchi and Akira, 
2010), nuclear translocation of transcription factors (such as NF-κB, AP-1, IRFs) 
(Troutman et al., 2014), and production of cytokines/chemokines and antimicrobial 
substances (Medzhitov, 2001; Selsted and Ouellette, 2005). In addition to the innate 
immune response, TLRs induce antigen uptake and presentation. Thus, TLR provides 
double protection to the host by (1) removing invading pathogens by directly phagocytosis 
and (2) triggering the adaptive immune response if the innate immune response is not 
sufficient to eradicate pathogens. However, bacterial pathogens have evolved several 
tactics to circumvent immune clearance by manipulating TLR signalling. 
PI3K/Akt finely tunes TLR signalling both positively and negatively. TLR2-mediated NF-
κB activation requires PI3K activity, as blocking PI3K using pharmacological inhibitors 
hinders phosphorylation of p65 NF-κB (Strassheim et al., 2004). While PI3K/Akt is 
involved in the pro-inflammatory response, this signalling cascade prevents excessive 
inflammation by promoting the anti-inflammatory response (Fukao and Koyasu, 2003). 
For example, the transcription factor FoxO1 enhances TLR4-mediated signalling, which 
involves activation of Akt (Fan et al., 2010b). However, activated Akt negatively regulates 
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FoxO1, thereby putting the brake on TLR4 signalling. Although the role of PI3K in 
inflammation remains controversial, it is undeniable that owing to its role in cellular 
proliferation and survival, PI3K is beneficial to the host during an immune response 
(Weichhart and Säemann, 2008).  
In addition, PI3K activity is critical for cytoskeleton rearrangement and bacterial invasion 
(Kierbel et al., 2005; Oviedo-Boyso et al., 2011). Therefore, inhibiting PI3K activity may 
be a potential target to reinforce host barrier. However, although many studies have been 
done with myeloid cells, the role of PI3K/Akt in airway epithelial cells in response to 
bacterial pathogens remains unclear.    
The aims of this chapter were to investigate modulation of PI3K, MAPK and NF-κB 
signalling by S. aureus and Bcc in bronchial epithelial cells, and particularly the role of 
PI3K in bacterial invasion.   
4.2 PI3K activity regulates S. aureus invasion of airway epithelial cells  
To assess S. aureus and Bcc adhesion, human airway epithelial 16HBE cells were 
infected by MRSA252, MSSA NCTC 6571, or B. multivorans 13243 at an MOI of 50 for 2 
hours. E. coli HB101 and S. Typhimurium NTB6 were used as the negative and positive 
control, respectively. Adhered bacteria were counted by determining the viable count of 
the epithelial cell lysates and presented as a percentage of the inoculum (Figure 4.1A). 
The resulted showed that cellular adherence by MRSA252 was 1-fold higher than MSSA 
NCTC 6571, whereas only minimal amount of B. multivorans 13243 (4.6% ± 1.4%) 
attached to 16HBE cells. To assess S. aureus and Bcc internalisation, 16HBE cells were 
exposed to MRSA252, MSSA NCTC 6571, or B. multivorans 13243 (MOI 50) for 2 hours, 
followed by 1- or 2-hour antimicrobial treatment to eliminate extracellular bacteria. The 
number of internalised bacteria was determined using viable count and shown as a 
percentage of adherence (Figure 4.1B). Although less amount of MSSA NCTC 6571 and 
B. multivorans 13243 adhered on epithelial cells, their percent of internalisation was 
higher than MRSA252.  
To investigate the role of PI3K/Akt in bacterial adherence and invasion, two structurally 
distinct pharmacological inhibitors of PI3K, LY294002 (Vlahos et al., 1994) and 
wortmannin (Arcaro and Wymann, 1993) were used. In Figure 4.2A and B, 16HBE cells 
were treated with 10 μM LY294002 30 minutes prior to bacterial infections. LY294002 
upregulated marginally the adherence of MRSA252 and S. Typhimurium NTB6, whereas 
B. multivorans 13243 attachment was reduced by 60%. Only minimal numbers of 
MRSA252 and MSSA NCTC 6571 entered into epithelial cells, and this was decreased 
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with LY294002. The invasion assay was also performed with a higher concentration of 
LY294002 (30 μM) and wortmannin (100 nM) (Figure 4.2C and D). MRSA252 and MSSA 
NCTC 6571 maintained the same level of adherence, whereas LY294002 caused a 
modest reduction, and wortmannin caused a modest increase of adherence of B. 
multivorans 13243. LY294002 reduced the invasion of MRSA252, MSSA NCTC 6571 and 
B. multivorans 13243 by more than 50%. In contrast, wortmannin only caused a decrease 
for B. multivorans 13243. Further invasion assays were performed with Bcc isolates 
(Figure 4.2E and F). In comparison with the CF-related pathogens B. multivorans 13243 
and B. cenocepacia J2315, the environmental isolate B. anthina J2552 did not adhere to 
epithelial cells. Although the pretreatment of PI3K inhibitors was extended to 1 hour, no 
effect was observed on adherence. Internalisation of B. anthina J2552 was blocked by 
LY294002.  Altogether, in the process of invasion, PI3K is not involved in adherence but 







Figure 4.1 Pilot study of adherence to and invasion of airway epithelial 16HBE cells. 
(A) Adherence of MRSA252, MSSA NCTC 6571, or B. multivorans 13243 to 16HBE cells at 2 
hours post infection (MOI 50). E. coli HB101 and S. Typhimurium NTB6 were used as the negative 
control and the positive control, respectively. (B) Invasion of 16HBE cells by MRSA252, MSSA 
NCTC 6571, or B. multivorans 13243 was quantified after 1 or 2 hours antibiotic treatment. Data 
are presented as mean ± SEM from three independent experiments performed in duplicate. *, 





































































































Figure 4.2 Inhibition of bacterial adherence and internalisation by pharmacological 
inhibitors of PI3K. 
(A and B) After 30 minutes treatment with LY294002 (10 μM), 16HBE cells were infected with 
MRSA252, MSSA NCTC 6571, B. multivorans 13243, E. coli HB101 or S. Typhimurium NTB6 (50 
MOI) for 2 hours with the presence of LY294002. 16HBE cells were washed 3 times with DPBS to 
remove nonadherent bacteria and subsequently lysed in 1% saponin (100 μL) to quantify adhered 
bacteria using viable count. The percentage of adhered bacteria was normalised against the 
inoculum. Alternatively, extracellular adherent bacteria were killed with antibiotics for another hour 
(2 hours for Bcc strains) to measure the amount of internalised bacteria. The percentage of 
internalised bacteria was calculated against the number of adhered bacteria. Adherence (A) and 
invasion (B) are shown as mean ± SEM from four independent experiments, each performed in 
duplicate. Data were analysed using two-way ANOVA following Bonferroni's multiple comparisons 
test. *, p<0.05. 
(C and D) After 30 minutes treatment with LY294002 (30 μM) or wortmannin (100 nM), 16HBE 
cells were challenged with MRSA252, MSSA NCTC 6571, B. multivorans 13243, E. coli HB101 or 
S. Typhimurium NTB6 (50 MOI) with the presence of inhibitors. Adherence (C) and invasion (D) 
were assessed as previous and are shown as mean ± SEM from three independent experiments 
in duplicate. Data were analysed using repeated measures two-way ANOVA following Dunnett’s 
multiple comparisons test.  
(E and F) After 1 hour treatment with LY294002 (30 μM) or wortmannin (100 nM), 16HBE cells 
were infected with B. multivorans 13243, B. cenocepacia J2315, B. anthina J2552, E. coli HB101 
or S. Typhimurium NTB6 (50 MOI) with the presence of inhibitors. Adherence (E) and invasion (F) 
were assessed as previous and are shown as mean ± SEM from three independent experiments, 
each performed in duplicate. Data are analysed using repeated measures two-way ANOVA 








































































































































































































































































































































4.3 Modulation of PI3K/Akt signalling by S. aureus isolates 
Akt is the major downstream target of PI3K and activated at Ser473 and Thr308 through 
a dual phosphorylation mechanism. In order to study the role of PI3K, airway epithelial 
16HBE cells were infected with planktonic (Figure 4.3) or biofilm (Figure 4.4) MRSA252 
or MSSA NCTC 6571 cultures, and phospho-Akt (Ser473) and phospho-Akt (Thr308) 
were analysed by immunoblotting. Although planktonic S. aureus cultures were used at a 
high dose (108 CFU/mL), they failed to activate Akt from 5 to 30 minutes. With their biofilm 
counterparts, phospho-Akt (Ser473) peaked at 15 minutes but no significant difference 
was observed (Figure 4.4A and C). 
 
 
Figure 4.3 Planktonic MRSA252 or MSSA NCTC 6571 do not affect PI3K activity.  
Human airway epithelial 16HBE cells were starved overnight. LY294002 (10 μM) overnight was 
used as negative control and TNFα (100 ng/mL) for 15 minutes was used as positive control. Cells 
were infected with MRSA252 or MSSA NCTC 6571 culture (108 CFU/mL) for the time indicated. 
Cell lysates were analysed by immunoblotting to quantify phospho-Akt (Ser473 and Thr 308). The 
fluorescence signals were normalised against total Akt and are presented as mean ± SEM from 
three independent experiments.      
p-AktS473 p-AktT308
Akt Akt

































































Figure 4.4 Biofilm MRSA252 or MSSA NCTC 6571 do not affect PI3K activity.  
Human airway epithelial 16HBE cells were starved overnight. LY294002 (10 μM) overnight was 
used as the negative control and TNFα (100 ng/mL) for 15 minutes was used as the positive control. 
Cells were infected with MRSA252 or MSSA NCTC 6571 culture (108 CFU/mL) for the time 
indicated. Cell lysates were analysed by immunoblotting to quantify phospho-Akt (Ser473 and 
Thr308). The signals were normalised against total Akt. Data are presented as mean ± SEM from 
three independent experiments. *, p<0.05 compared with the control using repeated measures 












































































4.4 B. cenocepacia J2315 and S. aureus supernatants modulating 
PI3K/Akt, MAPK and NF-κB signalling in human airway epithelial cells  
To investigate the effect of B. cenocepacia on MAPK signalling, 16HBE cells were 
challenged with the robust IL-8 inducer J2315 (Figure 3.3), at various MOIs (Figure 4.). 
With an MOI of 5, one-fold upregulation of phosphorylation of p38 was observed at 30 
and 60 minutes post infection.  In contrast, phosphorylation of Erk was not changed by 
any treatment. With 50 MOI, the level of phosphorylation of p38 and Erk did not change. 
J2315 failed to activate NF-κB signalling, as no increase in phosphorylation of IκBα was 
observed. Furthermore, higher MOI (100) of J2315 did not activate phosphorylation of 
IκBα or p65.  
Since it has been reported that S. aureus supernatants suppress TLR2 agonist 
Pam3CSK4-activated NF-κB pathway in human bronchial epithelial cells, to replicate this 
in our system, 16HBE cells were stimulated with different concentrations of MSSA NCTC 
6571 supernatant (Chekabab et al., 2015). When the cells were treated with lower dilution 
of MSSA NCTC 6571 supernatant (10% v/v, Figure 4.A and B), only a minimal increase 
in phosphorylation of p38 was observed at 60 minutes post stimulation, whereas 
phosphorylation of Erk was significantly inhibited at 15 minutes. In contrast, 25% (v/v) 
MSSA NCTC 6571 supernatant downregulated phosphorylation of p38 at 5 and 30 
minutes, and recovered back to baseline at 240 minutes (Figure 4.C). The bacterial culture 
medium trypticase soy broth (TSB, 10% v/v, 2 hours stimulation) has previously been 
shown to significantly downregulate Erk signalling in airway epithelial S9 cells but not 
16HBE cells (Below et al., 2009). In Figure 4.C and D, 4 hours treatment with 25% (v/v) 
LB did not change phosphorylation of p38 but increased phosphorylation of Erk by 50%. 





Figure 4.5 B. cenocepacia J2315 has no effect on MAPK or NF-κB signalling. 
Airway epithelial 16HBE cells were stimulated with B. cenocepacia J2315 at various MOIs (A and 
B, MOI=5; C-F, MOI=50; G and H, MOI=100) for the indicated time. (A and B) TNFα (20 ng/mL) 
and IL1β (20 ng/mL) for 20 minutes were used as the positive control. (E-H) TNFα (20 ng/mL) for 
5 minutes was the positive control. Phosphorylation of p38, Erk, IκBα, and p65 were detected by 
western blotting and the fluorescence signals were normalised against p38. Data are shown as 
mean ± SEM from three independent experiments and analysed using repeated measures one-



































































































































Figure 4.6 Analysis of Erk and p38 by MSSA NCTC 6571 supernatant. 
16HBE cells were incubated with 10% (v/v) (A and B) or 25% (v/v) (C and D) MSSA NCTC 6571 
conditioned medium for the indicated time. In C and D, cells were treated with 25% v/v LB medium 
for 4 hours as a control for LB. Western blots on cell lysates were done to measure phospho-p38, 
phospho-Erk. Membranes were reprobed with loading control total p38 and Erk antibodies. Data 
are shown as mean ± SEM from three independent experiments. *, p<0.05 compared with the 













































































To optimise the dose of stimuli, 16HBE cells were treated with increasing dose of B. 
cenocepacia J2315 or MSSA NCTC 6571 supernatant for 1 hour (Figure 4.7). A dose-
dependent increasing trend was observed with J2315. In contrast, S. aureus supernatant 





Figure 4.7 MAPK response to B. cenocepacia J2315 live bacteria or MSSA NCTC 6571 
supernatant.  
Phosphorylation of p38 and Erk of 16HBE cells after stimulated with B. cenocepacia J2315 (A and 
B) or MSSA NCTC 6571 supernatant (v/v, C and D) for 1 hour. Phospho-p38 and phospho-Erk of 
cell lysates were measured by western blot. Membranes were reprobed with loading control total 
p38 and Erk antibodies. Data are shown as mean ± SEM from three independent experiments and 
analysed using repeated measures one-way ANOVA following Dunnett’s multiple comparisons test. 
*, p<0.05. 
 



































































As surface structures (such as lipopeptides, flagellin and LPS) of B. cenocepacia play 
important roles in host-pathogen interactions, the potentially damaging effect of 
centrifugation in the bacteria preparation process should be considered (Peterson et al., 
2011). In Figure 4., 16HBE cells were infected with unwashed J2315 at an MOI of 5 for 
up to 180 minutes and phosphorylation of Akt was observed with maxima at 120 minutes. 
The Akt downstream target GSK-3β was phosphorylated marginally compared to the 
control. For the MAPK family, phosphorylation of p38 showed a 1-fold increase at 120 
minutes, whereas phosphorylation of Erk peaked at 5 minutes, followed by a decrease 
and then a secondary rise at 120 minutes. For NF-κB signalling, J2315 upregulated 
phosphorylation of p65, particularly after 120 minutes. Except for NF-κB, TNFα failed to 
activate PI3K/Akt and MAPK signalling as a positive control. Due to differential signalling 
response to unwashed J2315 culture comparing with washed culture (Figure 4.), a further 
experiment was performed to directly compare the difference. As shown in Figure 4., 
washed and unwashed J2315 cultures were used to stimulate 16HBE cells for 5 and 120 
minutes. Although no significant difference was shown in phosphorylation of Akt and GSK-
3β, a higher level of phosphorylation of Akt was observed with unwashed culture at 120 
minutes. Both washed and unwashed cultures had 2-fold higher phosphorylation of p38 
at 120 minutes compared with the control (Figure 4.C). In contrast, with washed culture, 
phosphorylation of Erk showed a 1-fold increase comparing 120 to 5 minutes, whereas 
with unwashed culture a 1-fold increase in phosphorylation of Erk exhibited both at 5 and 
120 minutes, which is consistent with Figure 4.D. Similar to the previous results, washed 




Figure 4.8 Host signalling modulation by unwashed B. cenocepacia J2315 culture. 
16HBE cells were infected by B. cenocepacia J2315 unwashed culture at an MOI of 5 for the 
indicated time. TNFα (20 ng/mL) for 5 minutes was used as the positive control. Phosphorylation 
of Akt (A), GSK-3β (B), p38 (C), Erk (D), p65 (E) of cell lysates were measured by western blot 
and normalised against total p38. (F) Western blot analysis for levels of phosphorylated Akt, 
phosphorylated GSK-3β, phosphorylated p38, phosphorylated Erk, phosphorylated p65, and p38 
in cell lysate following B. cenocepacia J2315 stimulation. Protein bands representative of three 
independent experiments. Data are shown as mean ± SEM. *, p<0.05 compared with the control 
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Figure 4.9 Comparison of washed and unwashed B. cenocepacia J2315 culture on 
stimulating 16HBE signalling. 
Overnight culture of B. cenocepacia J2315 were cultured into exponential phase. The culture was 
divided into two portions. Washed culture was centrifuged to collect bacteria and washed by DPBS 
once. Washed and unwashed culture were adjusted to the same optical density. 16HBE cells were 
challenged by B. cenocepacia J2315 at an MOI of 5 for 5 or 120 minutes. TNFα (20 ng/mL) for 5 
minutes was used as the positive control. Phosphorylation of Akt (A), GSK-3β (B), p38 (C), Erk 
(D), p65 (E) of cell lysates were measured by western blot and normalised against total p38. (F) 
Western blot analysis for levels of phosphorylated Akt, phosphorylated GSK-3β, phosphorylated 
p38, phosphorylated Erk, phosphorylated p65, and p38 in cell lysate following B. cenocepacia 
J2315 stimulation. Protein bands representative of three independent experiments. Data are 
shown as mean ± SEM. *, p<0.05 compared with the control using repeated measures one-way 
ANOVA following Tukey’s multiple comparisons test.    
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4.5 Discussion 
In this chapter, we investigated cellular invasion and signalling cascades mediated by S. 
aureus and Bcc isolates in human bronchial epithelial 16HBE cells.  
S. aureus is identified as an extracellular pathogen associated with skin and soft tissue 
infections in the traditional classification, whereas Bcc are dual intracellular/extracellular 
style pathogens (Wiersinga et al., 2006). However, there is growing evidence of an 
intracellular phase of S. aureus (Garzoni and Kelley, 2009). Here we assessed invasion 
by S. aureus and B. multivorans, as well as two control strains, in 16HBE cells. At 2 hours 
post infection, adherence of MRSA252, MSSA NCTC 6571 and B. multivorans 13243 
showed 45%, 25% and 10% of S. Typhimurium NTB6, respectively, whereas 
internalisation was 3%, 15% and 20%. This suggests their infective lifestyles in the host 
are consistent with the previous study (Silva, 2012). Phosphoinositide in the cell is 
essential for membrane dynamics, actin polymerisation and vesicle trafficking. Therefore, 
by disrupting phosphoinositide homeostasis, pathogens are able to enhance their uptake 
by host cells (Ham et al., 2011). Gessain et al. (2015) gave further insight into the critical 
role of PI3K. Despite no intrinsic PI3K activity in placental epithelial cells, a surface protein 
of Listeria monocytogenes InlB activates PI3K/Akt, which enables bacterial invasion 
(Gessain et al., 2015),  
To elucidate the role of PI3K in airway epithelial cell membrane permissiveness, we 
pretreated 16HBE cells with PI3K specific inhibitors LY294002 or wortmannin, followed 
by an invasion assay. LY294002 inhibits PI3K activity by competing the ATP binding site 
of catalytic subunit p110 reversibly, whereas wortmannin irreversibly causes covalent 
modification of p110 kinase and leads to a conformation rearrangement (Walker et al., 
2000). LY294002 (30 minutes treatment) failed to affect adherence of tested isolates, with 
the exception of B. multivorans 13243. However, the downregulation effect was not 
consistent with a longer pretreatment period (1 h). This part requires more replicates to 
validate the results. Of note, although only minimal amounts of S. aureus entered into 
epithelial cells, a consistent decrease was seen with LY294002, suggesting internalisation 
of S. aureus requires PI3K activity. This result is consistent with a study working with 
polarised MDCK cells and P. aeruginosa strain K (Kierbel et al., 2005). In addition, 
although pharmacological inhibition of Akt subverts S. aureus entry into endothelial cells 
as well, inhibition of Akt phosphorylation on Thr308 residue does not affect entry, 
suggesting S. aureus internalisation may be associated with phosphorylation of Akt on 
Ser473 (Oviedo-Boyso et al., 2011). Unexpectedly, although wortmannin is a more potent 
(IC50=5 nM) PI3K inhibitor compared with LY294002 (IC50=1.4 μM), in our model 
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wortmannin failed to cause changes similar to LY294002. We found similar results in 
Figure 3.4, in which wortmannin did not reduce bacteria-induced IL-8, except for B. 
cenocepacia J2315. This might be due to the instability of wortmannin in the presence of 
nucleophiles (Yuan et al., 2007).  
PI3K/Akt, MAPK and NF-κB are known to play critical roles in response to bacterial 
pathogens (Krachler et al., 2011). However, pathogens have evolved to exploit these 
pathways in order to promote survival and proliferation inside the host. First, we 
investigated activation of PI3K by planktonic or biofilm culture of S. aureus isolates. 
16HBE cells endogenously express phosphorylated-Akt at a relative high level, which 
might leave a very small window of unphosphorylated-Akt for S. aureus. This might 
explain why no visible trend was seen in cells stimulated with S. aureus. Then we 
assessed the ability of B. cenocepacia J2315 to activate PI3K. Activation of Akt leads to 
phosphorylation and inactivation of GSK-3β (Ser9). Phosphorylation of Akt (Ser473) 
peaked at 2 hours, but did not upregulate phosphorylation of GSK-3β. As a key regulator 
of numerous cellular functions, positive or negative dysregulation of PI3K/Akt in epithelial 
cells by bacteria has been reported in many studies. For example, invasion of P. 
aeruginosa to either the apical or basolateral surface of polarised airway epithelial Calu-
3 cells via pili or flagellin requires PI3K/Akt signalling, and ultimately leads to entry into 
host cells (Bucior et al., 2012). Apart from invasion, PI3K is a bacterial target to manipulate 
programmed cell death, depending on the cell types and stage of infection (Knodler et al., 
2005). At early stages of infection, the Salmonella effector SopB is proved to be anti-
apoptotic by continual activation of Akt in HeLa cells, whereas in macrophages, the 
effector SipB induces cell death in macrophages, thereby escaping phagocytosis 
(Hernandez et al., 2003).  
We further performed a pilot study of the time and dose response to B. cenocepacia J2315 
and S. aureus cell-free supernatant on host signalling. As IL-8 expression is associated 
with NF-κB (Elliott et al., 2001) and MAPK signalling pathways (Bhattacharyya et al., 
2011), these pathways might be involved in B. cenocepacia and S. aureus infections. The 
B. cenocepacia ET-12 lineage strain K56-2 has been reported to significantly upregulate 
phosphorylation of Akt, Erk and NF-κB at an MOI of 5 in 16HBE cells within 30 minutes of 
stimulation (Gillette et al., 2013). In parallel, B. cenocepacia BC7 (isolated from a CF 
patient who died of cepacia syndrome and is able to induce a robust IL-8 response), 
triggers phosphorylation of p38 and JNK in immortalised CF bronchial epithelial IB3 cells, 
whereas an environmental B. cepacia strain fails to show any activation of these pathways 
(Sajjan et al., 2008). This indicates that activation of MAPK signalling is related to more 
intense lung inflammation caused by Bcc isolates.  
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In contrast, in our system B. cenocepacia J2315 failed to active these pathways even at 
a high MOI. During the process of preparing the strain, in order to remove metabolites 
and secreted products, bacterial cultures were centrifuged twice (5000 g for 10 minutes), 
which might potentially cause damage to bacterial surface structures. Therefore, we 
performed same experiments using J2315 culture without centrifugation steps. 
Phosphorylation of Akt, p38, Erk and p65 increased at 120 minutes post-infection. Of note, 
J2315 without the centrifugation step caused a transient Erk phosphorylation at 5 minutes 
post-infection and peaked again at 120 minutes, which was reproduced in Figure 4.9. 
Centrifugation is likely to damage surface structures such as LPS and flagellin. D’Elia et 
al. observed a similar bi-phasic activation pattern of Erk and p38 in response to B. 
pseudomallei in vitro and in vivo (D’Elia et al., 2017). Thirty-minutes post-infection, murine 
alveolar macrophages exhibit transient phosphorylation of p38 and Erk1, and at 2 h post-
infection exhibited sustained activation. D’Elia et al. (2017) proposed that the transient 
activation at the early stage is associated with host defence and during the latter stage of 
infection host cells might initiate cell death as indicated by continuous Erk activation. B. 
pseudomallei might modulate the dynamics of Erk activation to delay apoptosis, thereby 
contributing to intracellular survival. Another member of MAPK family, JNK, has shown to 
be involved in J2315-induced TNFα and IL-1β production in macrophages. In our 
experiments we were unable to detect phosphorylation of JNK. In addition, we 
investigated the effect of S. aureus supernatant on host signalling cascades, as it has 
been reported that S. aureus supernatant is able to induce different cellular response in 
human tracheal gland cells compared to live bacteria, particularly a huge upregulation of 
IL-6 and IL-8 production (Moreilhon et al., 2005). However, in our system, MSSA NCTC 
6571 supernatant failed to show consistent modulation on MAPK signalling. Although 
same conditions (10% v/v, 60 minutes stimulation) were used in Figure 4.6A and B and 
Figure 4.7C and D, the downregulation on phosphorylation of Erk was not reproduced. 
This might be caused by repeated propagation of cell lines, or phenotype variance of 
bacterial culture.      
4.6  Conclusion 
In this chapter we assessed S. aureus and Bcc isolates to adhere to and enter into airway 
epithelial cells. Of note, S. aureus internalisation but not adhesion is PI3K-dependent. 
Hence, PI3K is a critical target for barrier permissiveness by S. aureus. In addition, a 
preliminary study on the ability of S. aureus, Bcc live bacteria and S. aureus supernatant 
to modulate host signalling was carried out. PI3K/Akt, MAPK and NF-κB signalling was 
unchanged when 16HBE cells were infected with bacterial cultures prepared with 
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centrifugation, whereas undamaged B. cenocepacia J2315 culture induced a bi-phasic 
activation of Erk during the early and the latter stage of infection. This may indicate that 
B. cenocepacia suppresses Erk activity to delay host apoptosis in order to promote 






























Chapter 5  Investigating Host Response 






















Over the past decades, abundant research has focused on single-species 
microorganisms and single virulence factors. However, the complex nature of infectious 
diseases such as airway infections is often associated with multiple species including 
bacteria, fungi and viruses. Yet we have much less understanding regarding polymicrobial 
communities within the infection sites, the net impact on progression and manifestations 
of infectious diseases and host responses to polymicrobial infections. Hence, elucidating 
the mechanisms of host-pathogen interactions in the context of polymicrobial communities 
is required to protect against such infection diseases.  
Synergism and antagonism are terms that can be applied to describe the cooperative / 
competitive polymicrobial interactions in disease progression. According to Murray et al. 
(2014), synergism is ‘an interaction of two or more microbes in an infection site that results 
in enhanced disease compared to infections containing the individual microbe acting 
alone’.  In contrast, the definition of antagonism is ‘the presence of two or more species 
protects the host from disease that occurs when only one species is present’ (Nguyen and 
Oglesby-Sherrouse, 2016). Synergistic interactions between S. aureus and P. aeruginosa 
have been discovered in many studies, including increased antimicrobial tolerance and 
enhanced virulence (Dalton et al., 2011; DeLeon et al., 2014; Fugère et al., 2014; Hoffman 
et al., 2006). For example, clinical isolates of P. aeruginosa and B. cenocepacia co-culture 
exhibit stronger biofilm formation and elicit increased pro-inflammatory responses in a 
murine chronic lung infection model (Bragonzi et al., 2012). Conversely, S. aureus has 
demonstrated an antagonistic effect in polymicrobial infections. In a 5-year predictive 
multivariate survivorship model of cystic fibrosis patients, Liou et al. (2001) discussed 
some known risk factors such as age, gender, and frequency of acute pulmonary 
exacerbations, and revealed that harbouring S. aureus promotes survivorship, whereas 
B. cepacia has a negative effect on survivorship. Indeed, Bcc species are notoriously 
associated with ‘cepacia syndrome’, which is characterised with rapid lung function 
decline and mortality, particularly B. cenocepacia (Boussaud et al., 2008). However, it is 
peculiar that S. aureus has protective effects and the reason remains unclear. It may be 
due to low-level pro-inflammatory or even anti-inflammatory property of S. aureus, 
partially antagonising excessive inflammation and tissue damage resulting from P. 
aeruginosa and Bcc infections (Chavakis et al., 2007). Consistent with this finding, a study 
by Ahlgren et al. (2015) compared clinical outcomes (for example, lung function and 
exacerbation rate) of a cohort of 84 CF adults grouped into S. aureus infection only, P. 
aeruginosa infection only, and neither S. aureus nor P. aeruginosa. Patients with S. 
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aureus infections had a better clinical outcome and the presence of S. aureus appeared 
a marker of less severe disease in patients compared to those who are infected with P. 
aeruginosa (Ahlgren et al., 2015).  
S. aureus is known to possess a plethora of immunomodulation strategies. For example, 
cell wall component SpA is able to activate TNFR1, elicit IL-8 expression and an excessive 
inflammatory response and tissue damage (Gomez et al., 2004). S. aureus also 
manipulates host responses by blocking neutrophil recruitment (Spaan et al., 2013b), 
phagocytosis and completement activation (Jongerius et al., 2010b; Jusko et al., 2014), 
as well as disrupting the adaptive immune response (Wang et al., 2012). Hence, 
understanding the molecular mechanism how S. aureus manipulates the immune system 
to evade microbial killing may be useful for developing novel treatments against S. aureus 
infection, particularly MRSA-related infections.  
The survillence of innate immune system TLRs recognise numerous microbial ligands and 
trigger protective immune responses. TLRs occur either as a homodimer such as TLR4 
and TLR5, or form heterodimer such as TLR1/2 and TLR2/6. All the TLRs comprise an 
extracellular leucine-rich repreat domain and a cytoplasmic TIR domain (Lim and Staudt, 
2013). TLR and IL-1 receptor belong to the IL-1R/TLR superfamily as they contain 
homologous TIR domain which is responsible for signalling transduction, and thus 
signalling pathways are highly conserved between TLRs and IL-1R (Cohen, 2014). IL-1R 
and all TLRs except TLR3 recruit MyD88 as an adaptor protein, and ultimately lead to 
activation of NF-κB. Upon activation of TLRs, MyD88 is recruited to the receptors via its 
TIR domain, and interacts with IRAK1/2/4 via its death domain. Phosphorylation of IRAKs 
results in the activation of TRAF6, which is an E3 ubiquitin ligase. TRAF6, together with 
UEV1A and UBC13, synthesises ubiquitin chain and subsequently activates the kinase 
complex containing TAB1/TAB2/TAK1, which contributes to the activation of MAPK family 
and nuclear translocation of transcription factors (such as NF-κB and AP-1) and ultimately 
mounts a pro-inflammatory response (Chen, 2005). Modulation of any signal molecules 
would affect the intensity and duration of the response and cause harmful outcomes. 
Therefore, it is vital to fine tune TLR-mediated innate immune response to ensure a 
protective yet not excessive inflammatory response. 
The aims of this chapter were to determine the immunomodulation effect of S. aureus on 
co-infection of B. cenocepacia,  to reveal the potential molecular mechanisms, as well as 
to characterise the nature of S. aureus-secreted immunomodulation molecules.  
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5.2 Suppression of B. cenocepacia-induced IL-8 production by S. aureus 
supernatants   
Following co-stimulation with B. cenocepacia J2315 and S. aureus supernatants or heat-
killed bacteria, the neutrophil chemoattractant IL-8 released by airway epithelial 16HBE 
cells was measured using ELISA. As shown in Chapter 3, B. cenocepacia J2315 is able 
to induce a robust IL-8 production. To optimise MOI (the ratio of bacteria to cells), 16 HBE 
cells were infected with an MOI ranging from 0.04 to 25 (Figure 5.1A) and all groups 
showed significant upregulation of IL-8, with a peak at an MOI of 5. Therefore, we chose 
an MOI of 5, for 24 hours, for the subsequent experiments.  
Interestingly, although supernatants (LB medium) of MRSA252 or MSSA NCTC 6571 did 
not change IL-8 production compared to control, they significantly downregulated IL-8 
induced by J2315 (23% and 31% less than J2315-treated group, respectively). To 
determine whether this effect is medium-specific, the same experiment was performed 
using supernatant from bacteria cultured in TSB (Figure 5.1C). In contrast, supernatants 
from S. aureus cultured in TSB maintained the level of IL-8 production with the presence 
or absence of J2315, which indicates that the anti-inflammatory effect is medium-specific. 
Similarly, J2315-induced IL-8 production did not change with supernatant of MRSA252 
biofilm (cultured in LB) but decreased marginally with MSSA NCTC 6571 biofilm 
supernatant (p<0.05, Figure 5.1D).  
Surprisingly, heat treatment (95°C, 10 minutes) did not reverse the anti-inflammatory 
property of S. aureus supernatants (Figure 5.1E), whereas heat-killed (100°C, 1 hour) S. 
aureus was unable to modulate IL-8 production (Figure 5.1F). To validate the results, the 
same experiments were done with a series of S. aureus isolates, either supernatants 
(Figure 5.2A) or heat-killed bacteria (Figure 5.2B). Supernatants from all the tested 
isolates downregulated the level of IL-8 to varying levels (p<0.05), whereas heat-killed 
bacteria had no effect on J2315-induced IL-8 production. These data indicate that anti-
inflammatory substances exhibit in secreted products but not S. aureus cell surface 
structures. To confirm the suppressing effect is not due to cell damage, an MTT assay 
was used to assess cell viability (Figure 5.2C and D). Of note, supernatants of SH1000 
and RN4220, which caused a doubling in IL-8 production (Figure 5.2A), significantly 
reduced cell viability. This indicates the correlation between pro-inflammatory secreted 




Figure 5.1 The anti-inflammatory effect of S. aureus on B. cenocepacia J2315-induced IL-8. 
(A) Dose response of 16HBE cells to B. cenocepacia J2315 live bacteria for 24 hours. 16HBE cells 
were treated with B. cenocepacia J2315 at an MOI of 5, in the presence or absence of (B) S. 
aureus supernatants 10% (v/v in LB), (C) 10% (v/v in TSB), (D) 10% biofilm supernatants (v/v in 
LB), (E) heat-inactivated supernatants 10% (v/v in LB), (F) heat-killed S. aureus (5 MOI) for 24 
hours. The control group was treated with 10% (v/v) LB in B, D and E; 10% (v/v) TSB in C. IL-8 
release was measured by ELISA. Data represent mean ± SEM from 3 independent experiments 
performed in duplicate. Significance was compared to (A) the control or (B-F) J2315-treated group 













S. aureus supernatants (LB)
B. cenocepacia J2315
MRSA252 SN

































S. aureus supernatants (TSB)
B. cenocepacia J2315
MRSA252 SN

















S. aureus Biofilm Supernatants
B. cenocepacia J2315
MRSA252 SN



























































Figure 5.2 IL-8 response to co-stimulation with B. cenocepacia J2315 and different S. aureus 
supernatants or heat-killed S. aureus. 
16HBE cells were stimulated with B. cenocepacia J2315 (5 MOI), in the presence or absence of 
(A) S. aureus supernatants (10% v/v) for 24 hours, or (B) heat-killed S. aureus (5 MOI) for 24 hours. 
The control group was treated with 10% (v/v) LB in A. IL-8 release was measured by ELISA. Data 
represent mean ± SEM from 3 independent experiments performed in duplicate. Significance 
compared to J2315-treated group using 2-way ANOVA followed by Dunnett’s multiple comparisons 
test. (C, D) MTT assay was used to assess cellular cytotoxicity caused by S. aureus supernatants 
and heat-killed S. aureus. Results are expressed as percent of the control, representing mean ± 
SEM (n=3). Significance compared to the control using 1-way ANOVA followed by Dunnett’s 































































































































































































In order to study the modulation on host signalling by this co-stimulation model, 16HBE 
cells were treated with B. cenocepacia J2315 (50 MOI) and 25% (v/v) MSSA NCTC 6571 
supernatant for 5 minutes (Figure 5.3A and B). J2315 caused a marginal downregulation 
on phosphorylation of p38 and Erk, whilst S. aureus supernatant caused a rapid 
phosphorylation, particularly with Erk. Co-stimulation led to activation of p38 and Erk, 
which likely results from the effect of S. aureus. Following 1 hour pretreatment of S. aureus 
supernatant (25% v/v), 16HBE cells were infected with J2315 (50 MOI) for 5 minutes 
(Figure 5.3C, D and E). J2315 and S. aureus induced a marginal increase in 
phosphorylation of p38, whilst dramatically increasing phosphorylation of Erk and IκBα, 
which indicates S. aureus supernatant at a higher concentration is able to induce 
persistent phosphorylation of Erk and IκBα. However, when co-stimulation extended to 2 
hours some trends became visible (Figure 5.4), although not achieving statistical 
significance. B. cenocepacia J2315 caused activation of Akt, p38, Erk and p65, whereas 
S. aureus did not change any tested signalling. It is worth noting that unlike MRSA252 
supernatant, MSSA NCTC 6571 supernatant abolished phosphorylation of p38, Erk and 
p65 caused by B. cenocepacia J2315. Therefore, these findings suggest that S. aureus 
supernatants may suppress the pro-inflammatory effect of B. cenocepacia by blocking 




Figure 5.3 MAPK response to co-stimulation with B. cenocepacia J2315 and MSSA NCTC 
6571 supernatant. 
(A-B) 16HBE cells were treated with LB (25% v/v) as control, J2315 (50 MOI), S. aureus 
supernatant (25% v/v) for 5 minutes. (C-E) After 1 hour pretreatment with S. aureus supernatant 
(25% v/v), 16HBE cells were infected with J2315 (50 MOI). The control was treated with 25% (v/v) 
LB for 1 hour. Phosphorylation of p38, Erk and IκBα of cell lysates were measured using western 
blot and normalised against total p38, Erk and IκBα, respectively. Data are shown as mean ± SEM 
from three independent experiments. *, p<0.05 compared with the control using one-way repeated 
































































































Figure 5.4 PI3K, MAPK and NF-κB response to co-stimulation with B. cenocepacia J2315 
and MRSA252 or MSSA NCTC 6571 supernatant. 
16HBE cells were treated with LB (10% v/v) as the control, J2315 (5 MOI), with the presence or 
absence of S. aureus supernatant (10% v/v) for 2 hours. Phosphorylation of Akt (A), GSK-3β (B), 
p38 (C), Erk (D) and p65 (E) of cell lysates were measured using western blot and normalised 
against total p38. (F) Western blot analysis for levels of phosphorylated Akt, phosphorylated GSK-
3β, phosphorylated p38, phosphorylated Erk, phosphorylated p65, and p38 in cell lysate following 
S. aureus supernatants and B. cenocepacia J2315 co-stimulation. Protein bands representative of 
three independent experiments. Data are shown as mean ± SEM. *, p<0.05 compared with the 
















































































































5.3 Characterisation of anti-inflammatory factors in S. aureus 
supernatants 
It has been confirmed that the anti-inflammatory factors in S. aureus supernatant are heat-
stable and not associated with cell wall structures (Figure 5.1E-F). To determine the 
nature of the effectors, S. aureus supernatants were digested with the broad-spectrum 
serine protease, PK or heat-inactivated PK (Figure 5.5A). Co-stimulation with B. 
cenocepacia J2315 and PK-treated supernatants did not restore IL-8 production to the 
level as J2315-treated group; on the contrary, IL-8 production dropped to the same level 
of the control. This indicates that the effectors are not proteinaceous. To assess the 
approximate molecular weight, S. aureus supernatants were separated into different 
molecular cut-off fractions (Figure 5.5B). Although there was a weak positive control 
response in this series of experiments, supernatants <3 kDa still abolished IL-8 production 
back to the same level as the control, which indicates the anti-inflammatory molecules are 
small. In order to elucidate whether TLR is exclusively involved in S. aureus-induced anti-
inflammatory response, 16HBE cells were stimulated with up to 10 ng/mL IL-1β. However, 
IL-1β only induced half the amount of IL-8 induced by B. cenocepacia J2315. In addition, 
IL-1β / S. aureus supernatants co-stimulation caused a marginal increase rather than a 
decrease (Figure 5.5C). Therefore, a further experiment was done by co-stimulating with 
IL-1β and TNFα, which resulted in a similar level of IL-8 compared to J2315-treated group 
(Figure 5.5D). However, no effect of S. aureus supernatants was observed on IL-1β / 
TNFα-induced IL-8 production, indicating IL-1R and TNFR are not associated with this 
process and the suppressive effect does not appear to be a non-selective downregulation 
of IL-8 production.  
Taken together, the anti-inflammatory molecules in S. aureus supernatants are 






Figure 5.5 Characterisation of anti-inflammatory effectors in S. aureus supernatants. 
(A) S. aureus supernatants were treated with immobilised proteinase K for 1 hour at 37°C, or 
treated with heat-inactivated proteinase K (99°C for 1 hour) as the positive control. 16HBE cells 
were co-stimulated with B. cenocepacia J2315 (5 MOI) and proteinase K-treated S. aureus 
supernatants (10% v/v) for 24 hours.  
(B) S. aureus supernatants were filtered through selective membranes. 16HBE cells were treated 
with B. cenocepacia J2315 (5 MOI) and S. aureus supernatant fractions containing metabolites 
of >10 kDa, >3 kDa and <3 kDa for 24 hours. IL-8 release was measured by ELISA. Data represent 
mean ± SEM from 3 independent experiments performed in duplicate. Significance compared to 
J2315-treated group using 2-way ANOVA followed by Dunnett’s multiple comparisons test.  
(C) After 1 hour pretreatment of S. aureus supernatants (10% v/v), 16HBE cells were stimulated 
with increasing dose of IL-1β for 24 hours. Data represent mean ± SEM from 3 independent 
experiments performed in duplicate. Significance was compared to the control using 2-way ANOVA 
followed by Dunnett’s multiple comparisons test.  
(D) 16HBE cells were co-stimulated with IL-1β (1 ng/mL) / TNFα (10 ng/mL) and S. aureus 
supernatants (10% v/v) for 24 hours. B. cenocepacia J2315 (5 MOI) was the positive control. Data 
represent mean ± SEM from 3 independent experiments performed in duplicate. *, p<0.05 
compared to IL-1β / TNFα-treated group or J2315-treated group using 2-way ANOVA followed by 
















































































































5.4 16HBE cells are hypo-responsive to Pam3CSK4, LPS but not flagellin 
As a Gram-negative bacterium with flagella, B. cenocepacia J2315 potentially binds to 
and activates TLR2, TLR4 and TLR5 (de C Ventura et al., 2008; West et al., 2008). To 
determine which TLR is involved in B. cenocepacia / S. aureus polymicrobial infection 
setting, 16HBE cells were co-stimulated with TLR2, TLR4 and TLR5 agonists, Pam3CSK4, 
LPS and flagellin, respectively, and with the presence or absence of MSSA NCTC 6571 
supernatant (Figure 5.6). None of the agonists induced IL-8 production as well as J2315, 
and only flagellin triggered a dose-dependent, significantly upregulated IL-8 response, 
indicating the pro-inflammatory property of J2315 is associated with multiple virulence 
factors. Moreover, with all agonists a marginal drop of the IL-8 response was seen with 






Figure 5.6 Pro-inflammatory response to TLR2, 4, or 5 agonists and S. aureus supernatant. 
16HBE cells were co-stimulated with increasing dose of Pam3CSK4, LPS, flagellin and MSSA 
NCTC 6571 supernatant (10% v/v) for 24 hours. B. cenocepacia J2315 (5 MOI) was the positive 
control. IL-8 release was measured by ELISA. Data represent mean ± SEM from 3 independent 
experiments performed in duplicate. *, p<0.05 compared to control using 2-way ANOVA followed 
by Dunnett’s multiple comparisons test.  
0.1






























To investigate host signalling responses to Pam3CSK4 and flagellin, the time course of 
the response was assessed. No effect was seen with Pam3CSK4 (10 μg/mL) up to 60 
minutes (Figure 5.7), whereas flagellin (1 μg/mL) caused a transient phosphorylation of 
Akt, GSK-3β, p38, Erk and p65 between 15 and 30 minutes (Figure 5.8), which is 
consistent with the IL-8 response. This indicates that flagellin might play a major role in 
the B. cenocepacia induced pro-inflammatory response.  
Following pretreatment with the TLR4 antagonist LPS-RS, stimulation with J2315 showed 
significant downregulation in IL-8 production (14% decrease compared to the J2315-
treated group), to the same level as S. aureus supernatants (Figure 5.9A). In contrast, co-
stimulation with TLR5 antagonist hTLR5fc and J2315 did not have any effect compared 




Figure 5.7 Time course of Pam3CSK4 on PI3K, MAPK and NF-κB activation. 
16HBE cells were treated with Pam3CSK4 (10 μg/mL) for 5-60 minutes, TNFα (20 ng/mL, 5 minutes) 
as the positive control. Phosphorylation of Akt (A), GSK-3β (B), p38 (C), Erk (D) and p65 (E) of 
cell lysates were measured using western blot and normalised against total p38. (F) Western blot 
analysis for levels of phosphorylated Akt, phosphorylated GSK-3β, phosphorylated p38, 
phosphorylated Erk, phosphorylated p65, and p38 in cell lysate folowing Pam3CSK4 stimulation. 
Protein bands representative of three independent experiments. Data are shown as mean ± SEM. 
*, p<0.05 compared with control using one-way repeated measures ANOVA following Dunnet’s 
multiple comparisons test.    
 
 











































































Figure 5.8 Time course of flagellin on PI3K, MAPK and NF-κB activation. 
16HBE cells were treated with flagellin (1 μg/mL) for 5-180 minutes, TNFα (20 ng/mL, 5 minutes) 
as the positive control. Phosphorylation of Akt (A), GSK-3β (B), p38 (C), Erk (D) and p65 (E) of 
cell lysates were measured using western blot and normalised against total p38. (F) Western blot 
analysis for levels of phosphorylated Akt, phosphorylated GSK-3β, phosphorylated p38, 
phosphorylated Erk, phosphorylated p65, and p38 in cell lysate folowing flagellin stimulation. Data 
are shown as mean ± SEM from three independent experiments. *, p<0.05 compared with control 























































































Figure 5.9 TLR4 antagonist LPS-RS inhibits B. cenocepacia J2315-induced IL-8 production 
but not TLR5 antagonist hTLR5 fc. 
(A) Following pretreatment with TLR4 antagonist LPS-RS (2 μg/mL) for 1 hour, 16HBE cells were 
stimulated with LPS (10 μg/mL) or B. cenocepacia J2315 (5 MOI) for 24 hours. Cells were also co-
stimulated with S. aureus supernatants (10% v/v,1 hour pretreatment) and B. cenocepacia J2315 
(5 MOI) for 24 hours as positive controls. (B) After 24 hours pretreatment with TLR5 antagonist 
hTLR5-fc (100 ng/mL), 16HBE cells were stimulated with TLR5 agonist flagellin (1 μg/mL) or B. 
cenocepacia J2315 (5 MOI) for 24 hours. Cells were co-stimulated with S. aureus supernatants 
(10% v/v,1 hour pretreatment) and B. cenocepacia J2315 (5 MOI) for 24 hours as positive controls. 
IL-8 release was measured by ELISA. Data represent mean ± SEM from 3 independent 
experiments performed in duplicate. *, p<0.05 compared to B. cenocepacia-J2315 treated group 






































































Several lines of evidence indicate that S. aureus induces an anti-inflammatory response 
to facilitate persistence inside the host. For example, the secreted protein SSL3 blocks 
TLR2 activity and thereby inhibits IL-8 production in vitro (Bardoel et al., 2012), as well as 
antagonising TLR2 function as a virulence factor during in vivo infection of mice (Koymans 
et al., 2017). Additionally, S. aureus-induced IL-10 production enhances persistence by 
hindering local pro-inflammatory responses in an acute murine skin infection model 
(Leech et al., 2017). Because of the large reservoir of immunomodulatory effectors 
(Thammavongsa et al., 2015), multi-drug resistance, and biofilm formation, S. aureus is a 
major threat to human health in infectious diseases.  
Extensive studies have focused on the interactions between S. aureus and P. aeruginosa 
as they are two prevalent pathogens involved in CF lung infections. However, S. 
aureus/Bcc interactions and their impact on host response have not been assessed before. 
Herein, we demonstrate that in the context of S. aureus / B. cenocepacia co-infection, 
supernatants from S. aureus isolates dampen B. cenocepacia live bacteria-induced IL-8 
production in airway epithelial cells, indicating that S. aureus releases anti-inflammatory 
compounds into the broth. Interestingly, all the supernatants from S. aureus isolates block 
J2315-induced IL-8 production to different levels (p<0.05). Hyperinflammatory isolates 
such as SH1000, RN4220 and USA400, where the live bacteria induced strong IL-8 
production (Figure 3.3A), exhibit inhibitory effect on IL-8 production as well. This indicates 
the components may be widely expressed in S. aureus.  
In agreement with our findings, Chekabab et al. (2015) demonstrated that S. aureus 
supernatants suppress P. aeruginosa supernatant-induced cytokine (IL-8 and CXCL-2) 
production through inhibiting TLR1/2 and TLR4, but not TLR5. However, the inhibition 
effect is medium-specific, as it presents with LB-cultured supernatant but not TSB-
cultured supernatant, which is in parallel with our results. LB and TSB are rich media, 
commonly used to culture aerobic microorganisms such as S. aureus. Compared to TSB, 
LB has simple ingredients and is not buffered. Unfortunately, we are unable to confirm 
which medium reflects the physiological condition of the airway milieu. Several studies 
have applied synthetic cystic fibrosis sputum medium (Kumar and Cardona, 2016) or 
artificial sputum medium (Fung et al., 2010) to resemble the sputum from CF patients and 
observed changes in gene expression responsible for virulence. Since differences in 
compositions of culture media may change metabolism and subsequently affect 
modulation of metabolites on host response, S. aureus should be cultured in a medium 
that reflects the nutrition of the infected airway. Nevertheless, S. aureus grows poorly in 
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synthetic CF sputum medium and thus is not possible to compare the differences of S. 
aureus supernatant cultured in synthetic CF sputum medium and LB (Bernier et al., 2016).  
S. aureus biofilm supernatants are able to impair macrophage phagocytosis (Hanke and 
Kielian, 2012) and S. aureus biofilms programme macrophages to the alternative 
activated M2 phenotype (Thurlow et al., 2011), It was unexpected that in our results S. 
aureus biofilm supernatants had very little effect on J2315-induced IL-8, except a marginal 
downregulation by MSSA NCTC 6571 biofilm supernatant (p<0.05). Supernatants from 
planktonic and biofilm S. aureus contain different features (such as proteases in biofilm 
supernatant) which result in different signalling activation and cytokine production. 
Compared to the planktonic counterparts, biofilm supernatants cause apoptosis, 
downregulate phosphorylation of p38 and JNK, upregulate phosphorylation of Erk, and 
induce higher level of cytokines at 4 hours but lower level at 24 hours post-stimulation in 
human keratinocytes (Secor et al., 2011). Differential host responses directed towards 
planktonic and biofilm supernatants indicate that S. aureus modifies its expression of 
virulence factors at different stages of infection. Brady et al. (2018) developed 
epicutaneous (planktonic) and subcutaneous mesh (biofilm) S. aureus infection models 
in mice and compared cytokine production at 7 days and 21 days. Although the day 7 
biofilm model caused higher levels of CXCL1, CXCL2, IL-1α and IL17A production 
compared to the planktonic counterpart, the host response was ineffective and insufficient 
for microbial clearance. On day 21, S. aureus biofilm shifted to a dormant state, which 
results in S. aureus being less detectable to the immune system as shown by a decrease 
in cytokines released (Brady et al., 2018).  
In further experiments, the effects of heat-treatment, heat-killed S. aureus, proteinase K-
treatment, and different molecular weight cut-off fractions were examined in order to 
determine the nature of the anti-inflammatory compounds in S. aureus supernatants. The 
compounds were characterised as small (<3 kDa), heat-resistant, non-proteinaceous, and 
non-cell wall components, in agreement with previous work (Chekabab et al., 2015). 
When co-stimulated with J2315, IL-8 production elicited by proteinase K-treated S. aureus 
supernatants showed a 50% decrease compared to deactivated proteinase K-treated S. 
aureus supernatants. This indicates that the anti-inflammatory components is less likely 
to be peptides or proteins. The decrease may result from pro-inflammatory components 
in S. aureus supernatants spontaneously degraded by proteinase K. Apart from releasing 
immunosuppression modulators, S. aureus produces multiple virulence factors that have 
pro-inflammatory effects. For example, MRSA-derived small, heat- and protease-resistant 
molecules induce nitric oxide in human sinonasal epithelial cells (Carey et al., 2015). The 
level of nitric oxide and inflammation status are positively correlated as nitric oxide plays 
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a critical role in microbial killing, wound healing as well as facilitating chemokine 
production (Trifilieff et al., 2000). In contrast with our observations, S. aureus supernatants 
are reported to induce a stronger magnitude of cytokine, chemokine and prostaglandin E2 
expression than live bacteria (Moreilhon et al., 2005). These findings suggest that S. 
aureus as a prevalent pathogen modulates the immune response to benefit colonisation 
and infections.   
Inhibition of IL-8 production by S. aureus supernatants has been previously reported in 
TNFα-treated HUVEC cells (Tajima et al., 2006). The inhibitory effect of supernatants is 
also abolished by proteinase K or trypsin treatment but, in contrast with our findings, is 
sustained after heat-treatment. Thus, the anti-inflammatory component is defined as heat-
stable protein. Of note, S. aureus supernatants are treated with proteinase K and trypsin, 
respectively; however, they did not describe whether the final supernatants contain 
proteinase K. Serine proteases such as trypsin activate proteinase-activated receptor-2 
which subsequently activates NF-κB (Buddenkotte et al., 2005). Although there is no 
evidence showing that proteinase K causes activation of NF-κB, it may be that stimulating 
HUVEC cells with residual proteinase K (10 μg/mL according to their method) initiated an 
inflammatory response that masked the S. aureus inhibitory activity.  
Immunosuppression is also observed with commensal S. salivarius, which dwells in the 
oral and nasopharyngeal cavity. S. salivarius secretes small heat-resistant proteins which 
hinder p65 nuclear translocation and subsequently IL-8 production, both under baseline 
condition and on co-stimulation with different stimuli (TNFα, IL-1β, P. aeruginosa, flagellin, 
LL-37) (Cosseau et al., 2008; Kaci et al., 2014; 2011). The abilities of commensal bacteria 
to cause a low pro-inflammatory response, induce an anti-inflammatory respons and 
regulate gene expression involved in airway epithelial tight junctions contribute to immune 
tolerance and homeostasis in the mucosal barrier. Our results showed that the inhibitory 
effect of S. aureus secreted products was TLR-specific, as S. aureus supernatants did 
not affect IL-1β/TNFα-induced IL-8 production. In contrast, S. aureus supernatants 
suppress TNFα-induced IL-8 production in the HUVEC model. However, the supernatants 
are obtained using a different method (incubated for 1 hour in mammalian cell culture 
medium) which may elicit different metabolites (Tajima et al., 2006). Overall, S. aureus 
may induce anti-inflammatory responses to prevent phagocytosis and hinder the adaptive 
immune response. Thus, it is critical to elucidate the immune evasion mechanisms used 
by S. aureus to design novel treatments.  
Following co-stimulation with B. cenocepacia J2315 and S. aureus supernatant, we 
assessed activation of PI3K, MAPK and NF-κB and found that MSSA supernatant 
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abolished phosphorylation of p38, Erk and p65 caused by J2315. MRSA252 supernatant 
did not affect either baseline or J2315-induced phosphorylation, which correlates with its 
less downregulation effect on IL-8 production compared to MSSA NCTC 6571. Our results 
are in partial agreement with the results by Chekabab et al., (2015) as they showed S. 
aureus supernatants block NF-κB activation but not p38. However, Chekabab et al. (2015) 
stimulated airway epithelial Beas-2B cells with synthetic TLR2/1 agonist Pam3Csk4, 
whereas B. cenocepacia contains more complicated ligands. Additionally, the 
downstream signalling cascades engaged in the anti-inflammatory response may be cell 
type-specific. Nasal S. aureus isolates utilise PI3K and Erk signalling cascades to induce 
IL-10 production whereas they induce TNFα in a p38-dependent pathway in human PBMC 
(Peres et al., 2015).This suggests that through expressing unique ligands in the process 
of infection, S. aureus manipulates different signalling cascades to initiate immune 
tolerance or phagocytosis.    
Chekabab et al. (2015) suggest that the inhibitory effect of S. aureus supernatant is 
through TLR signalling. In order to determine which TLR signalling was modulated by S. 
aureus-secreted products, first we stimulated 16HBE cells with TLR2/1, TLR4 and TLR5 
agonists, respectively. Pam3CSK4, LPS and flagellin caused 22%, 62% and 151% 
increases in IL-8 production at the highest dose (10 μg/mL) compared to the control. The 
result was unexpected, as in Beas-2B cells Pam3CSK4 was found to be the most 
efficacious IL-8 inducer, LPS showed a dose-dependent manner of inducing IL-8  and 
flagellin did not affect IL-8 production (Chekabab et al., 2015). The hypo-responsiveness 
to TLR2/1 and TLR4 agonists may result from low expression and location of the receptors 
and the accessory molecules, as in polarised primary human airway epithelial cells TLR2 
is mainly expressed on the basolateral surface and TLR4 is weakly expressed on the 
apical surface (Ioannidis et al., 2013). For example, airway epithelial Beas-2B cells display 
lower sensitivity to S. aureus and TLR2 agonists compared to Gram-negative bacteria in 
terms of IL-8 production, which is associated with low expression of TLR2 and missing 
expression of the co-receptor CD36; whereas monocytes exhibit a robust TNFα response 
to both Gram positive and negative bacteria (Mayer et al., 2007). This indicates that 
mucosal epithelia may use this mechanism to prevent an excessive inflammatory 
response and maintain homeostasis. In contrast, B. cenocepacia J2315 can induce TLR2 
and TLR4, but not TLR5 expression in Beas-2B cells, whereas only TLR5 is required for 
a pro-inflammatory response (de C Ventura et al., 2008).  
Further we assessed the effect of Pam3CSK4 and flagellin on signalling cascades. It is 
not surprising that Pam3CSK4 did not affect PI3K, MAPK and NF-κB. In agreement with 
our result, Pam3CSK4 is able to trigger marginal phosphorylation of p38 but not NF-κB 
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activity and IL-8 production in human airway epithelial cells (Winder et al., 2009). Flagellin 
has been reported to activate phosphorylation of p38 and p65 in airway epithelial Calu-3 
cells (Illek et al., 2008), phosphorylation of Akt in human colonic epithelial cells (Sang et 
al., 2006), and phosphorylation of p38, Erk, JNK and IκBα in mouse bone marrow-derived 
dendritic cells (Feuillet et al., 2006). In our system, airway epithelial cells were most 
sensitive to flagellin, as flagellin activated several signalling pathways and induced a 
strong IL-8 response. In the following experiment, we pretreated the cells with TLR4 and 
TLR5 antagonists, respectively, followed by stimulation with TLR agonists or J2315. 
Compared to J2315-treated cells, only the TLR4 antagonist caused a decrease in IL-8 
production. However, the magnitude of reduction was similar to S. aureus supernatants. 
This suggests that S. aureus-secreted products may block TLR4 and subsequently 
suppress the B. cenocepacia-induced pro-inflammatory response. Recently, a family of 
small (~20-25 amino acids) secreted peptides, namely PSMs are able to bind to TLR4 
without activation in THP-1 cells (Chu et al., 2018). PSM α1-α3 suppress pro-inflammatory 
cytokines production induced by high mobility group box-1 protein (belongs to the danger-
associated molecular pattern family) by subverting TLR4 signalling. However, although 
heat stability of these factors is unclear, according to our results the anti-inflammatory 
factors may not be peptide/protein. Thus, further characterisation needs to identify the 
Staphylococcal factors.   
5.6 Conclusions 
In this chapter, we demonstrate that S. aureus isolates produce immunomodulatory 
factors that subvert the B. cenocepacia-induced inflammatory response in airway 
epithelial cells. The factors are characterised as small, heat-stable, non-proteinaceous, 
non-cell wall components. Additionally, we demonstrate S. aureus subverts the B. 
cenocepacia-induced inflammatory response by attenuation of TLR4-mediated p38, Erk 




































6.1    Host responses to monomicrobial infections 
The innate immunity protects the lower respiratory tract and controls its homeostasis. 
Intensity and duration of the immune response, along with pathogenesis of the pathogens, 
determine the clinical outcome (Strobel et al., 2016). The host-pathogen interactions in 
the scenario of polymicrobial infections have been acknowledged with increasing 
frequency, yet still require intensive investigation (Bragonzi et al., 2012; Dai et al., 2018; 
Flight et al., 2015; Sibley et al., 2008). This thesis began by assessing pathogenesis of 
individual bacterial pathogens that belong to S. aureus and Bcc species, and the effect 
on host signalling cascades and pro-inflammatory responses. Upon recognition of 
incoming microorganisms, certain signalling pathways are activated to initiate the 
expression of pro-inflammatory cytokines and chemokines as key events to conduct and 
amplify the immune response (Weitnauer et al., 2016; Whitsett and Alenghat, 2015).  
To enhance the potential of pathogenesis, multiple virulence factors are required at 
different stages of infection (Foster et al., 2014; Kim et al., 2010). Thus, microbial invasion 
was assessed by viable count using airway epithelial cells grown on plastic. Airway 
epithelial cells are vulnerable to S. aureus invasion, and might be killed by virulent isolates 
(Strobel et al., 2016). We observed that epithelial cells accumulated higher amounts of S. 
aureus on the cell membrane compared to clinical Bcc isolates, whereas the latter was 
taken up more readily. To assess invasion on intact polarised epithelial monolayers, 
airway epithelial cells were cultured on transmembrane inserts, infected apically with live 
bacteria, and the integrity was monitored using TEER. In agreement with a previous study, 
our isolates of interest, MRSA252 and B. multivorans 13243 both breached polarised 
epithelial monolayers in 24 h. By disturbing the actin cytoskeleton, S. aureus or B. 
multivorans invade the epithelium barrier (Schwab et al., 2002; Soong et al., 2011). B. 
multivorans also leads to extensive cell death (Schwab et al., 2002), which might explain 
why B. multivorans caused higher level of FITC-dextran flux compared to S. aureus. This 
indicates that B. multivorans resulted in a higher barrier permeability than S. aureus.  
As PI3K regulates cytoskeleton rearrangement (Gessain et al., 2015), we assessed 
invasion by treating airway epithelial cells with pharmacological PI3K inhibitors prior to 
live bacteria exposure. In line with a previous study (Kierbel et al., 2005), PI3K is required 
for S. aureus internalisation. In addition, because of the asymmetric localisation of TLRs 
on the apical and basolateral surfaces (Ioannidis et al., 2013), an invasion assay using 
polarised epithelial monolayers would closer reflect the physiological condition. This is 
further supported by the fact that P. aeruginosa binds to distinct receptors on the apical 
and basolateral surfaces, with different binding affinity (Bucior et al., 2010). Hence, a 
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future experiment is guaranteed to perform the invasion assay using epithelial cells grown 
on permeable membranes, and comparing invasion by infecting the monolayers from the 
apical and the basolateral surface.           
As bacteria in biofilms are more resistant to antimicrobial substances and host clearance, 
biofilm formation is a key virulence factor for persistence and immune evasion. The 
strength of biofilm development by S. aureus is positively correlated with disease severity 
(Domenico et al., 2018). Both S. aureus and Bcc are known to form biofilm in close 
proximity to the apical mucosal surface (Krismer and Peschel, 2011; Schwab et al., 2002). 
Our results showed that S. aureus and Bcc developed differential amounts of biofilms. 
Some clinical isolates such as B. multivorans 13243, B. cenocepacia J2315, and MSSA 
NCTC 10788 formed more robust biofilms compared to non-invasive strains.  
Heterogenicity was also observed in IL-8 production induced by S. aureus isolates. IL-8 
is a biomarker for monitoring infections (Kraft et al., 2015). As the main receptor for 
recognising S. aureus, TLR2 activation depends on ligand abundance on the bacterial 
surface. Hence, differential activation of TLR2-mediated signalling by S. aureus clinical 
isolates may result from differences in bacterial metabolic activity, capsule expression and 
cell wall synthesis (expression of lipoproteins and SpA) (Hilmi et al., 2014; Peres et al., 
2015). Bcc has prototypical ligands for TLR2, TLR4, and TLR5 (West et al., 2009). CF-
related isolates B. cenocepacia J2315 and B. multivorans 13243 have been reported to 
induce high amounts of IL-8 in 16HBE cells, with a higher level induced by J2315 (Kaza 
et al., 2010). However, in our system, B. cenocepacia J2315 but not B. multivorans 13243 
caused a significant increase in IL-8 production; thus, B. cenocepacia J2315 was chosen 
for further experiments.     
The quantification of the IL-8 protein level was 24 h post-bacterial stimulation. However, 
the duration should be carefully decided, as protein levels are highly dynamic and 
regulated by mRNA level, translation, and degradation. Protein levels at steady state are 
dominated by mRNA levels, whereas under stress conditions, in addition to transcription 
changes, a delay occurs between changes in transcription and translation level, especially 
immune response proteins (Jovanovic et al., 2015; Liu et al., 2016). Hence, a time course 
of IL-8 protein level would be useful to decide the duration of bacterial stimulation. By 
doing so, the gap between different treatments might be larger.  
IL-8 production is initiated by TLR-mediated downstream signalling cascades (Lim and 
Staudt, 2013). To elucidate which pathways are modulated by S. aureus and Bcc, 
phosphorylation of key signalling proteins following bacterial stimulation was investigated 
using western blot. In agreement with Gillette et al. (2013), B. cenocepacia J2315 led to 
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phosphorylation of p38, Erk and p65 NF-κB, whereas phosphorylation maintained the 
same when exposed to Staphylococcal strains and their supernatants. The minimal 
expression of TLR2 co-receptor CD36 restricts recognition of Gram-positive bacteria, 
which leads to airway epithelial cells hypo-responsive to Gram-positive bacteria but not 
Gram-negative bacteria (Mayer et al., 2007). On the other hand, p38 and Erk contribute 
to IL-8 mRNA stability in lung epithelial cells, supporting the observation that J2315 
induces higher level of IL-8 compared to S. aureus isolates (Bhattacharyya et al., 2011).   
6.2     Host response to polymicrobial infections and the comparison with 
monomicrobial infections 
B. cenocepacia J2315 is  strong IL-8 inducer on its own, and in a chronic P. aeruginosa/ 
B. cenocepacia co-infection model, significant higher amounts of cytokines and 
chemokines were induced by co-infection compared to single infections (Bragonzi et al., 
2012). The net impact of polymicrobial infections leads to different host responses, and 
the consequences may be detrimental, insignificant or beneficial to the host (McArdle et 
al., 2018; Ramsey and Whiteley, 2009; Sibley et al., 2008). To elucidate the host response 
to S. aureus/B. cenocepacia co-infection, 2 isolates of S. aureus that downregulated IL-8 
production without causing significant cell damage were chosen and supernatants from 
overnight cultures were prepared.  
The data presented here is the first time to show the anti-inflammatory effect of S. aureus 
products when co-stimulated with live B. cenocepacia bacteria. Similar results were 
observed when Staphylococcal supernatants co-stimulated bronchial epithelial cells with 
supernatant of a  close relative of Burkholderia, P. aeruginosa (Chekabab et al., 2015). 
Chekabab et al. (2015) demonstrated that the synthetic ligand for TLR1/2 induced IL-8 to 
the same level of as P. aeruginosa supernatant, and the response was abolished by S. 
aureus supernatant, whereas Beas-2B cells were hypo responsive to LPS or flagella. 
Further experiments confirmed that S. aureus supernatant blocked TLR2-mediated NF-
κB signalling but not MAPK (Chekabab et al., 2015). To demonstrate which signalling 
pathway is involved in our system, we co-treated airway epithelial cells with S. aureus 
supernatant and B. cenocepacia J2315, followed by the assessment of phosphorylation 
using western blotting. Although not achieving statistical significance, S. aureus 
supernatant abolished phosphorylation of p38, Erk and p65 NF-κB. This is the first time 
showing the inhibitory effect of S. aureus on MAPK signalling.  
The findings in this thesis demonstrate the antagonistic interaction between S. aureus and 
B. cenocepacia on inducing the pro-inflammatory response. By inhibiting MAPK and NF-
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κB signalling cascades activated by B. cenocepacia, S. aureus-secreted products reduce 
IL-8 production in airway epithelial cells. This might shed light on a novel Staphylococcal 
immune evasion mechanism through inducing anti-inflammatory responses. Further, 
identification of the host target might provide a novel treatment for chronic inflammation 
resulted from excessive immune responses.      
6.3     Interpretation of the host receptor for S. aureus anti-inflammatory 
factor(s)  
TLRs are the major sensors for B. cenocepacia, and TLR2 is the most important PRR to 
detect S. aureus (Askarian et al., 2018). Chekabab et al. (2015) reported that P. 
aeruginosa activated TLR2 is blocked by S. aureus which subsequently subverts TLR2-
mediated NF-κB signalling. To distinguish whether the effect was TLR-specific, upon 
stimulation with IL-1β and TNFα, airway epithelial cells were treated with S. aureus 
supernatants. In contrast, while IL-1β / TNFα induced the same level of IL-8 as B. 
cenocepacia J2315, S. aureus supernatants did not abolish IL-8 production. Hence, the 
anti-inflammatory effect of S. aureus is TLR-specific.  
To illustrate which TLR is targeted by S. aureus, airway epithelial cells were exposed to 
S. aureus supernatants, together with TLR2/1, TLR4 and TLR5 agonists, respectively. 
However, although flagellin led to a significant increase in IL-8 production, none of the 
other TLR agonists elicited IL-8 to the same level as B. cenocepacia J2315 even at a high 
concentration. In addition, only flagellin significantly upregulated PI3K/Akt, MAPK and NF-
κB signalling cascades in 16HBE cells. This is consistent with a previous study that only 
TLR5 but not TLR2 and TLR4 plays a central role in B. cenocepacia-induced pro-
inflammatory responses (de C Ventura et al., 2008).  
The hypo-sensitivity to TLR ligands have three possible explanations. The commercially 
purchased TLR ligands were isolated from other microorganisms. The acylation of LPS 
lipid A contributes to abnormal pro-inflammatory responses to whole-cell lysates and 
highly purified LPS from B. cenocepacia (De Soyza et al., 2004; Zughaier et al., 1999). 
Hence, stimulation with isolated TLR ligands from B. cenocepacia J2315 would closely 
reflect the host response to B. cenocepacia. Secondly, the hypo-responsiveness might 
result from restricted expression of TLRs. The epithelial cell line 16HBE exhibits a low but 
inducible level of TLR2 expression and a relatively higher level of TLR4 (Bailey et al., 
2009; Pace et al., 2008), which explains hypo-responsiveness to Gram-positive bacteria 
compared to Gram-negative bacteria (Mayer et al., 2007). In addition, epithelial cells such 
as BEAS-2B are deficient in TLR2 co-receptor CD36, and TLR2/CD36 transfection results 
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in enhanced IL-8 production (Mayer et al., 2007). TLR5 is also present in 16HBE cells 
(Muir et al., 2004; Parker and Prince, 2013). Lastly, the differential responses to B. 
cenocepacia and TLR ligands might result from the additional receptors that are targeted 
by B. cenocepacia (Ganesan and Sajjan, 2011). For example, the O antigen of LPS from 
B. cenocepacia activates the inflammasome in a TLR4- and caspase-1-dependent 
manner (Kotrange et al., 2011). In addition, B. cenocepacia binds to TNFR1 and 
subsequently elicits robust IL-8 expression through an unknow ligand in CF airway 
epithelial cells (Sajjan et al., 2008). Hence, in addition to TLR activation, other host 
receptors might be involved in the disproportionate pro-inflammatory response to B. 
cenocepacia.   
Further experiments were performed with TLR antagonists. TLR4 but not TLR5 inhibitor 
reduced IL-8 production elicited by B. cenocepacia to the same level of S. aureus 
supernatants. Multiple Staphylococcal products are known to antagonise TLRs, such as 
TLR2 by SSL3 (Bardoel et al., 2012). The anti-inflammatory molecules present in 
Staphylococcal supernatant might be PSMα, which consists of 20 to 30 amino acids with 
about 2 to 3 kDa peptides (Berube et al., 2014). PSMα1-α3 of S. aureus have shown to 
disrupt the interaction between TLR4 and high motility group box-1 protein, and 
subsequently inhibit NF-κB signalling in HEK-Blue hTLR4 cells (Chu et al., 2018). 
However, PSMα is able to activate TLR2 signalling (Armbruster et al., 2016) and HEK-
Blue hTLR4 cells (InvivoGen, USA) are inactive to TLR2 ligands. What would be the net 
impact of PSMα if cells with the presence of TLR2 and TLR4 were used?  
In our system, the downregulation on IL-8 production by blocking TLR4 was minimal but 
significant. Alternatively, following confirmation of TLR isoforms expression in airway 
epithelial cells, we could compare chemokine responses to B. cenocepacia using wild 
type cells and TLR isoform knockdown cells. By doing so, it would confer an unbiased 
actual response showing the net impact of Staphylococcal products. In addition, using live 
bacteria would reflect the actual ligands shed from intact bacteria compared to using TLR 
agonists.  
As TLR4 is the only TLRs that requires both MyD88 and TRIF, this leads to a hypothesis 
that the anti-inflammatory effect of S. aureus results from blocking MyD88- and TRIF-
dependent signalling. So far, YopJ from Yersinia pseudotuberculosis is the only bacterial 
effector that blocks type I IFN and cytokine responses through suppressing MyD88 and 
TRIF in DC and macrophages (Rosadini et al., 2015; Rosadini and Kagan, 2015). Hence, 
by knocking out MyD88 and TRIF, respectively, it could be possible to evaluate the role 
of MyD88 and TRIF when airway epithelial cells are co-stimulated with B. cenocepacia 
and S. aureus supernatants.  
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6.4     Characterisation of S. aureus immunomodulatory factor(s) 
The nature of Staphylococcal products is defined as small (less than 3kDa), heat-stable, 
non-proteinaceous, and not cell wall-related. So far, the immunomodulatory molecules 
identified in S. aureus are mostly peptides or proteins (Bardoel et al., 2012; Chu et al., 
2018; Tajima et al., 2006; Tajima et al., 2008; Chekabab et al., 2015), in contrast to our 
results. In addition to the possibility that the molecules are non-proteinaceous, they might 
be proteinase K-resistant peptides/proteins as protease-resistant proteins have been 
reported before, mainly in prion and Mycoplasma (Abd-Elhadi et al., 2015; Butler et al., 
1991; Salta et al., 2014).  
Alternatively, with the assistance of in silico prediction, liquid chromatography-mass 
spectrometry/mass spectrometry (LC-MS/MS) could be applied to identify the 
Staphylococcal secretomes that interact with human TLR4 (Boleij et al., 2011a; Fels et al., 
2017). While computational technique provides rapid discovery of the potential candidates 
based on empirical data, in some cases the predicted secretomes might be poorly 
expressed. With major improvements in accuracy, efficiency and sensitivity, LC-MS/MS 
enables identification of small organic compounds such as proteins and sugars in the field 
of host-pathogen interactions (Portillo et al., 2011; Han et al., 2013; Schweppe et al., 
2015). However, this technique is vastly restricted by the ratio of macromolecules between 
host and pathogen (for example, human proteomes have about 20457 proteins while the 
prokaryotic counterparts have about 4423 proteins), which results in a decrease in the 
number of identified pathogen proteins when analysing mixed host and pathogen lysates 
(Fels et al., 2017). Identification of Staphylococcal immunomodulatory molecules would 
illustrate a novel immune evasion mechanism contributing to S. aureus pathogenesis, and 
implicate novel anti-Staphylococcal therapeutic interventions. 
6.5    Limitations 
This study has several limitations. Firstly, one difficulty throughout the project was 
inadequate phosphorylation to bacterial stimuli. Phosphatase inhibitors were included in 
the lysis buffer to inhibit phosphatase activity during cell lysis. However, the inadequate 
response could not be ascribed to the endogenous immune tolerance since the positive 
control TNFα failed to cause a significant increase in phosphorylation in several blots. 
Other pharmacological reagents such as EGF and phorbol 12-myristate-13-acetate could 
be applied as positive controls for Akt and MAPK activation (Rice et al., 2002). 
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Alternatively, techniques to assess cumulative responses such as ELISA, intracellular 
flow cytometry or mass spectrometry, might provide a clearer readout. 
Secondly, this project was limited to human airway cell lines. Although pulmonary 
epithelial cell lines and culture models are commonly used, there are inconsistencies 
between different phenotypes of cell lines (Kaza et al., 2010), and between cell lines and 
primary cells (Strobel et al., 2016) in the host response. Since polymicrobial respiratory 
infections are highly prevalent in CF individuals, CF-isolated primary tissues and 
immortalised cell lines would be critical for the understanding of biochemical, physiological 
and genetic mechanisms of host defence underlying CF defect (Gruenert et al., 2004).  
Thirdly, this study requires confirmation using in vivo models. Using animal models would 
provide a panorama of the host response to S. aureus/Bcc co-infection. Moreover, there 
is limited research using rodent models to study polymicrobial infections. In this project, 
due to cell damage caused by S. aureus, pro-inflammatory responses to S. aureus and 
Bcc live bacteria were not evaluated. Alternatively, murine models could be applied to 
assess host responses to either acute or chronic polymicrobial infections, by intratracheal 
injection or agar bead-based method, respectively (Kukavica-Ibrulj et al., 2014). These 
models would be useful to study microbial clearance, inflammatory responses, mortality 
and lung histopathology.    
Lastly, the interaction between S. aureus secreted products and TLR4 complex requires 
binding assays to be validated. Since antagonising TLR4, reduced B. cenocepacia J2315-
induced pro-inflammatory response, it is plausible that Staphylococcal products 
competitively bind to TLR4 complex. However, this requires separating S. aureus 
supernatant using chromatography and binding assays to confirm TLR4 is the host target 
(Nicholas et al., 2017; Fuchs et al., 2018).  
6.6    Final conclusions 
This thesis demonstrates the disruptive effect of two microorganism species, S. aureus 
and Bcc on human airway epithelial monolayers, as well as their modulation on host 
signalling cascades. S. aureus and Bcc are also able to adhere to and enter into airway 
epithelial cells. B. cenocepacia J2315 exposure leads to phosphorylation of MAPK and 
NF-κB cascades, which results in substantial IL-8 production. However, this robust pro-
inflammatory chemokine response is subverted by secreted molecules from S. aureus, 
partially through blocking TLR4 pathway. Preliminary characterisation describes the anti-
inflammatory molecules as small, heat-stable, non-proteinaceous, and not cell wall-
related factors. The findings might provide valuable insight into a novel Staphylococcal 
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immune evasion mechanism, as well as a resolution of tissue injury resulting from 
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